Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CASQ2,Calsequestrin-2,Lifestyle factors,X1050.Time spend outdoors in summer,45047,-0.0520416101861661,0.0262254296213677,-0.103443452244047,-0.000639768128285471,0.0472250784761221
CASQ2,Calsequestrin-2,Lifestyle factors,X1060.Time spent outdoors in winter,41927,-0.00216783074162203,0.0297080156585093,-0.0603955414323003,0.0560598799490562,0.94182983879818
CASQ2,Calsequestrin-2,Physical activities,X1070.Time spent watching television (TV),46347,0.0472131252369007,0.0267163016335738,-0.00515082596490397,0.0995770764387053,0.0772081857580467
CASQ2,Calsequestrin-2,Physical activities,X1080.Time spent using computer,41893,-0.0643691697227818,0.0280755114900245,-0.11939717224323,-0.00934116720233379,0.0218762174022972
CASQ2,Calsequestrin-2,Physical activities,X1090.Time spent driving,39712,0.00491691331799389,0.0307028206587491,-0.0552606151731543,0.0650944418091421,0.872768714289674
CASQ2,Calsequestrin-2,Lifestyle factors,X1160.Sleep duration,47633,-0.00478544502055242,0.0242981625953889,-0.0524098437075146,0.0428389536664097,0.843870907652884
CASQ2,Calsequestrin-2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32384,0.0466413733437221,0.0181952576678856,0.0109786683146663,0.0823040783727779,0.0103841008832593
CASQ2,Calsequestrin-2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32384,0.011219817516225,0.0162450462078177,-0.0206204730510977,0.0430601080835476,0.489798903588753
CASQ2,Calsequestrin-2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32384,-0.02301395446162,0.0191326595300437,-0.0605139671405056,0.0144860582172657,0.229065521742176
CASQ2,Calsequestrin-2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32384,0.00474491678838909,0.0195261452475142,-0.0335263278967388,0.043016161473517,0.808009161872526
CASQ2,Calsequestrin-2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32384,-0.0386893888808656,0.0198193792318123,-0.0775353721752177,0.000156594413486484,0.0509615963918621
CASQ2,Calsequestrin-2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32384,-0.0926646595058873,0.0380464419439516,-0.167235685716032,-0.0180936332957421,0.0148903449972879
CASQ2,Calsequestrin-2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32384,-0.037352722680745,0.0373909506661709,-0.11063898598644,0.03593354062495,0.317836009237016
CASQ2,Calsequestrin-2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32384,0.019426617284346,0.0293194445978369,-0.0380394941274144,0.0768927286961064,0.507615782151126
CASQ2,Calsequestrin-2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32384,-0.0249381161315462,0.0209365712379643,-0.0659737957579562,0.0160975634948638,0.233639357276403
CASQ2,Calsequestrin-2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32384,0.00700429993918806,0.0145874410899717,-0.0215870845971565,0.0355956844755326,0.631127149156388
CASQ2,Calsequestrin-2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32384,0.00741512771427327,0.0201842737924886,-0.0321460489190044,0.046976304347551,0.71335169968691
CASQ2,Calsequestrin-2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32384,-0.0143488467182645,0.0123676641202688,-0.0385894683939914,0.00989177495746244,0.246006162873637
CASQ2,Calsequestrin-2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32384,-0.00287026714194656,0.0154331474342131,-0.0331192361130042,0.0273787018291111,0.852464673546251
CASQ2,Calsequestrin-2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32384,-0.00506027019747867,0.0219526471867772,-0.0480874586835621,0.0379669182886047,0.817702659669144
CASQ2,Calsequestrin-2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32384,-0.0102955448456822,0.0207615391003715,-0.0509881614824104,0.030397071791046,0.619982185352882
CASQ2,Calsequestrin-2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32384,0.0296682241782302,0.0288774431794992,-0.0269315644535882,0.0862680128100486,0.30427099281792
CASQ2,Calsequestrin-2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32384,-0.0327640735725483,0.0274720557066602,-0.0866093027576023,0.0210811556125058,0.233048905757347
CASQ2,Calsequestrin-2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32384,0.0162059039352391,0.0163927115434168,-0.0159238106898578,0.048335618560336,0.322886972047643
CASQ2,Calsequestrin-2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32384,-0.00483132797745613,0.0153005732986834,-0.0348204516428756,0.0251577956879633,0.752192048567972
CASQ2,Calsequestrin-2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32384,-0.00243085426028503,0.0202796537219707,-0.0421789755553476,0.0373172670347775,0.904591815015043
CASQ2,Calsequestrin-2,Health and medical history,X120040.Fatigue severity over the past week,32391,-0.0196211728879183,0.0437295135125885,-0.105331019372592,0.0660886735967551,0.653664620651565
CASQ2,Calsequestrin-2,Health and medical history,X120041.Waking unrefreshed severity over the past week,32390,-0.00823433264794472,0.0437757300044293,-0.0940347634566261,0.0775660981607366,0.850800960362089
CASQ2,Calsequestrin-2,Health and medical history,X120042.Cognitive symptoms severity over the past week,32388,-0.028346211486864,0.0466449212533132,-0.119770257143358,0.0630778341696298,0.543402535749452
CASQ2,Calsequestrin-2,Health and medical history,X120098.Mobility problems today,32394,-0.0063944935703001,0.0512201400157344,-0.10678596800114,0.0939969808605394,0.900650732945157
CASQ2,Calsequestrin-2,Health and medical history,X120099.Self-care problems today,32394,-0.175770760105958,0.089013481724171,-0.350237184285333,-0.00130433592658241,0.048342110321429
CASQ2,Calsequestrin-2,Health and medical history,X120100.Problems doing usual activities,32394,0.00115236315836564,0.0483349821486897,-0.0935842018530661,0.0958889281697974,0.980979889213118
CASQ2,Calsequestrin-2,Health and medical history,X120101.Pain or discomfort today,32394,-0.0439456793505216,0.0438213364904027,-0.129835498871711,0.0419441401706677,0.315969838346149
CASQ2,Calsequestrin-2,Health and medical history,X120102.Anxiety or depression today,32394,-0.0259332292535256,0.0513965555893551,-0.126670478208662,0.0748040197016103,0.613873943146336
CASQ2,Calsequestrin-2,Health and medical history,X120103.Scale to indicate how health is today,32357,-0.000278202423602908,0.00535790903815899,-0.0107797041383945,0.0102232992911887,0.958590807475817
CASQ2,Calsequestrin-2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32369,-0.00686143666272151,0.0530313749085082,-0.110802931483398,0.0970800581579546,0.897056718259551
CASQ2,Calsequestrin-2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32347,0.053702260542584,0.0518748924272393,-0.047972528614805,0.155377049699973,0.300594886144775
CASQ2,Calsequestrin-2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32377,0.025889093983701,0.0439242279409447,-0.0602023927805507,0.111980580747953,0.555607430185555
CASQ2,Calsequestrin-2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32378,-0.00930219655467855,0.0448439216663948,-0.0971962830208124,0.0785918899114553,0.835675522064933
CASQ2,Calsequestrin-2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32379,0.0212307142798806,0.0538393717216505,-0.0842944542945544,0.126755882854316,0.69334480798313
CASQ2,Calsequestrin-2,Health and medical history,X120109.Feeling bad about self over the last two weeks,32354,-0.0430540614188438,0.0566542523806504,-0.154096396084919,0.067988273247231,0.44731071287345
CASQ2,Calsequestrin-2,Health and medical history,X120110.Trouble concentrating over the last two weeks,32376,0.064230535792667,0.0556954852547399,-0.0449326153066233,0.173393686891957,0.248844662018607
CASQ2,Calsequestrin-2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32368,-0.000973084834065206,0.0838868032083878,-0.165391219122505,0.163445049454375,0.990745058862704
CASQ2,Calsequestrin-2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32336,-0.215436875035366,0.131067242503071,-0.472328670341384,0.0414549202706523,0.100275469811906
CASQ2,Calsequestrin-2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",30420,0.0398433604049458,0.0577559617991423,-0.073358324721373,0.153045045531265,0.490310887734513
CASQ2,Calsequestrin-2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45631,-0.118577215404968,0.0628934215701711,-0.241848321682503,0.00469389087256722,0.0593939099676911
CASQ2,Calsequestrin-2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,44046,-0.0337436959412975,0.0378864528114028,-0.108001143451647,0.0405137515690519,0.373126107468764
CASQ2,Calsequestrin-2,Diet and food preferences,X1289.Cooked vegetable intake,47181,-0.0284473433220652,0.0251199664964973,-0.0776824776551999,0.0207877910110695,0.257453272078404
CASQ2,Calsequestrin-2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46762,-0.0353172234041428,0.026949977324193,-0.0881391789595611,0.0175047321512755,0.19004929116308
CASQ2,Calsequestrin-2,Diet and food preferences,X1309.Fresh fruit intake,47235,-0.00295590568749167,0.0260596394258014,-0.0540327989620624,0.048120987587079,0.909691848988173
CASQ2,Calsequestrin-2,Diet and food preferences,X1319.Dried fruit intake,45769,-0.0257950590839252,0.0263439441435353,-0.0774291896052544,0.0258390714374039,0.327509740169066
CASQ2,Calsequestrin-2,Health and medical history,X134.Number of self-reported cancers,47887,-0.0193110673315689,0.043777447023054,-0.105114863496755,0.0664927288336169,0.659130858220386
CASQ2,Calsequestrin-2,Health and medical history,X135.Number of self-reported non-cancer illnesses,47887,-0.0187253475488638,0.0248911863475938,-0.0675120727901476,0.0300613776924201,0.451885275666557
CASQ2,Calsequestrin-2,Health and medical history,"X136.Number of operations, self-reported",47887,-0.0472275323525813,0.0249400629982551,-0.0961100558291613,0.00165499112399858,0.0582849481966043
CASQ2,Calsequestrin-2,Health and medical history,X137.Number of treatments or medications taken,47887,-0.0304760857212126,0.0245548082493915,-0.07860350989002,0.0176513384475948,0.214564488378826
CASQ2,Calsequestrin-2,Diet and food preferences,X1438.Bread intake,47071,-0.00325772983366667,0.00365364436909259,-0.0104188727970882,0.00390341312975481,0.37259623408588
CASQ2,Calsequestrin-2,Diet and food preferences,X1458.Cereal intake,46690,-0.00347711331000501,0.0249412546816706,-0.0523619724860795,0.0454077458660694,0.889125754258275
CASQ2,Calsequestrin-2,Diet and food preferences,X1488.Tea intake,47093,-0.00247629287191285,0.00339937422865458,-0.00913906636007583,0.00418648061625012,0.466342330467895
CASQ2,Calsequestrin-2,Diet and food preferences,X1498.Coffee intake,46046,-0.00358351069669303,0.0249631792290945,-0.0525113419857183,0.0453443205923322,0.885855700082959
CASQ2,Calsequestrin-2,Diet and food preferences,X1528.Water intake,46431,-0.0251345559504076,0.0255515542535626,-0.0752156022873903,0.024946490386575,0.325283646005851
CASQ2,Calsequestrin-2,Lifestyle factors,X1568.Average weekly red wine intake,38735,-0.0583969090518956,0.0302439927007388,-0.117675134745344,0.000881316641552388,0.0535201639923182
CASQ2,Calsequestrin-2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,38730,-0.00991265253634941,0.0307133306226808,-0.0701107805568038,0.050285475484105,0.746891156104989
CASQ2,Calsequestrin-2,Lifestyle factors,X1588.Average weekly beer plus cider intake,38756,0.0237582014374401,0.038384539337015,-0.0514754956631093,0.0989918985379894,0.535957597094734
CASQ2,Calsequestrin-2,Lifestyle factors,X1598.Average weekly spirits intake,38693,0.017481844085306,0.0341940779956279,-0.0495385487861247,0.0845022369567366,0.609181445998941
CASQ2,Calsequestrin-2,Lifestyle factors,X1608.Average weekly fortified wine intake,38763,-0.0593940198887396,0.0555595510540073,-0.168290739954594,0.0495027001771147,0.285080728117037
CASQ2,Calsequestrin-2,Lifestyle factors,X1737.Childhood sunburn occasions,42300,-0.00490026351127487,0.0292888096393743,-0.0623063304044485,0.0525058033818988,0.867129300499204
CASQ2,Calsequestrin-2,Health and medical history,X1807.Father's age at death,41635,-0.00245874488973374,0.0038754644608288,-0.0100546552329582,0.0051371654534907,0.525802963505881
CASQ2,Calsequestrin-2,Health and medical history,X1845.Mother's age,33545,0.00429133353602108,0.00916447630109152,-0.0136710400141183,0.0222537070861605,0.639611776424156
CASQ2,Calsequestrin-2,Health and medical history,X1873.Number of full brothers,47447,0.00515049915392192,0.0243156446252589,-0.0425081643115856,0.0528091626194294,0.832250647738684
CASQ2,Calsequestrin-2,Health and medical history,X1883.Number of full sisters,47450,0.0249457843822492,0.0239580565256753,-0.0220120064080745,0.0719035751725728,0.297780978122747
CASQ2,Calsequestrin-2,Physical measures,X20015.Sitting height,47728,0.00608241166853352,0.00447350681765745,-0.00268566169407508,0.0148504850311421,0.17395330322726
CASQ2,Calsequestrin-2,Cognitive function,X20016.Fluid intelligence score,32059,-0.00227727264809133,0.0387386673000552,-0.0782050605561996,0.0736505152600169,0.953124489522865
CASQ2,Calsequestrin-2,Cognitive function,X20018.Prospective memory result,32341,-0.0485802287733163,0.0517819679063808,-0.150072885869823,0.05291242832319,0.348186373294506
CASQ2,Calsequestrin-2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),31952,-0.00214056596038219,0.00634188014073247,-0.0145706510362178,0.0102895191154534,0.735727897706619
CASQ2,Calsequestrin-2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),31932,-0.014105753333728,0.00631800537372102,-0.0264890438662212,-0.00172246280123485,0.025602989103079
CASQ2,Calsequestrin-2,Cognitive function,X20023.Mean time to correctly identify matches,47606,0.00154743719143337,0.00369482288918403,-0.00569441567136732,0.00878929005423407,0.675357215691542
CASQ2,Calsequestrin-2,Health and medical history,X20107#1.Illnesses of father_Heart disease,45149,-0.0113480786194933,0.0075024934507339,-0.0260529657829318,0.00335680854394511,0.13040310021785
CASQ2,Calsequestrin-2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44794,-0.00324672248776088,0.0162384901630789,-0.0350741632073955,0.0285807182318738,0.84152956462912
CASQ2,Calsequestrin-2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44765,0.00158337670117923,0.0221848365050656,-0.0418989028487493,0.0450656562511078,0.943102376430318
CASQ2,Calsequestrin-2,Health and medical history,X20107#12.Illnesses of father_Severe depression,44781,0.00630411541043895,0.0175344908974745,-0.0280634867486112,0.040671717569489,0.719204937325019
CASQ2,Calsequestrin-2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44788,0.00163209682765378,0.0133061904930262,-0.0244480365386776,0.0277122301939851,0.902379962248216
CASQ2,Calsequestrin-2,Health and medical history,X20107#2.Illnesses of father_Stroke,44916,0.00490424753476293,0.00978125726838885,-0.0142670167112792,0.0240755117808051,0.61610041848431
CASQ2,Calsequestrin-2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44873,0.0185586719320651,0.0121938989865574,-0.00534137008158741,0.0424587139457176,0.128033653679712
CASQ2,Calsequestrin-2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44791,0.0173257540308417,0.0156153121710117,-0.0132802578243413,0.0479317658860246,0.267212057860876
CASQ2,Calsequestrin-2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44925,0.0123376907464387,0.0110018250758228,-0.00922588640217392,0.0339012678950513,0.26212134902523
CASQ2,Calsequestrin-2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44963,-0.00192603975206973,0.00833396812814813,-0.0182606172832401,0.0144085377791006,0.817233853649271
CASQ2,Calsequestrin-2,Health and medical history,X20107#9.Illnesses of father_Diabetes,44853,-0.00256014996833555,0.0116773222098418,-0.0254477014996254,0.0203274015629543,0.82646436748241
CASQ2,Calsequestrin-2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46307,0.00549982226695396,0.00833730647135971,-0.0108412984169111,0.021840942950819,0.509476322387075
CASQ2,Calsequestrin-2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46195,0.00299261897177346,0.0122367944071864,-0.0209914980663119,0.0269767360098589,0.806800172465294
CASQ2,Calsequestrin-2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46138,-0.0364386953900513,0.026089081883485,-0.0875732958816818,0.0146959051015792,0.162517235776726
CASQ2,Calsequestrin-2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46168,-0.00823462649520583,0.013136619610082,-0.0339824009309665,0.0175131479405549,0.530767323794095
CASQ2,Calsequestrin-2,Health and medical history,X20110#2.Illnesses of mother_Stroke,46254,-0.015308756088219,0.00956709851680392,-0.0340602691811547,0.00344275700471666,0.109580649063547
CASQ2,Calsequestrin-2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46151,0.0054894633722145,0.017889610866233,-0.0295741739256021,0.0405531006700311,0.758958949197468
CASQ2,Calsequestrin-2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46148,-0.0108309350237173,0.0157681185167297,-0.0417364473165074,0.0200745772690728,0.492160505762599
CASQ2,Calsequestrin-2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46177,-0.00028743884614704,0.0124050818678907,-0.0246013993072129,0.0240265216149188,0.981514039208893
CASQ2,Calsequestrin-2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46195,0.00640664014869495,0.0141028428599889,-0.0212349318568833,0.0340482121542732,0.649631808482354
CASQ2,Calsequestrin-2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46335,-0.00781832712097669,0.00723044899530665,-0.0219900071517777,0.00635335290982434,0.279572982030966
CASQ2,Calsequestrin-2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46208,-0.008478763328677,0.0113879694550745,-0.030799183460623,0.013841656803269,0.456559775686178
CASQ2,Calsequestrin-2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43282,-0.0138814273385028,0.011885197651418,-0.0371764147352822,0.00941356005827656,0.242837963169837
CASQ2,Calsequestrin-2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43155,-0.0540555937626498,0.0466686454381047,-0.145526138821335,0.0374149512960355,0.246762524959303
CASQ2,Calsequestrin-2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43151,-0.0743624137079893,0.0487012193586417,-0.169816803650927,0.0210919762349484,0.126800128190784
CASQ2,Calsequestrin-2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43211,0.0286281089568234,0.0132987744404453,0.0025625110535506,0.0546937068600962,0.0313559382935756
CASQ2,Calsequestrin-2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43165,-0.00895722589117603,0.0281376578345048,-0.0641070352468055,0.0461925834644534,0.750233727741969
CASQ2,Calsequestrin-2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43181,-0.0245590859589579,0.0201343805129583,-0.0640224717643561,0.0149042998464403,0.222571718370011
CASQ2,Calsequestrin-2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43160,0.00599429600990392,0.0245092420116085,-0.0420438183328487,0.0540324103526565,0.806789843983699
CASQ2,Calsequestrin-2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43159,-0.0181557929364284,0.0240967490147555,-0.0653854210053491,0.0290738351324923,0.451186600945603
CASQ2,Calsequestrin-2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43174,0.0201482584237147,0.0173312156909568,-0.0138209243305607,0.0541174411779901,0.245030374060989
CASQ2,Calsequestrin-2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43182,-0.0158890284623965,0.0213960525320229,-0.0578252914251613,0.0260472345003684,0.457724148358471
CASQ2,Calsequestrin-2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43336,-0.0123861900468912,0.00877962487671093,-0.0295942548052447,0.0048218747114622,0.158323585618753
CASQ2,Calsequestrin-2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43235,-0.010595444004879,0.0125722828095919,-0.0352371183116791,0.0140462303019211,0.399372215409276
CASQ2,Calsequestrin-2,Mental health,X20127.Neuroticism score,42877,0.0094869766718479,0.0254057037050076,-0.0403082025899671,0.0592821559336629,0.708840796279957
CASQ2,Calsequestrin-2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32059,0.033442687739971,0.0389910328405432,-0.0429797366274937,0.109865112107436,0.391084083333399
CASQ2,Calsequestrin-2,Lifestyle factors,X20161.Pack years of smoking,30742,-0.00315352578037953,0.00706450710842009,-0.0169999597128829,0.0106929081521238,0.655330872983073
CASQ2,Calsequestrin-2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30742,-0.00414114509785659,0.00696523824188612,-0.0177930120519534,0.00951072185624022,0.55216927217098
CASQ2,Calsequestrin-2,Cognitive function,X20191.Fluid intelligence score,30287,0.0278700007690372,0.0457479111825584,-0.0617959051487774,0.117535906686852,0.542410239715134
CASQ2,Calsequestrin-2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,30287,0.064961585029562,0.0460992335066542,-0.0253929126434803,0.155316082702604,0.158838765804464
CASQ2,Calsequestrin-2,Cognitive function,X20240.Maximum digits remembered correctly,29648,-0.0159714317268225,0.049229037192776,-0.112460344624663,0.0805174811710183,0.745624741300528
CASQ2,Calsequestrin-2,Physical measures,X20255.Spirometry QC measure,42398,-0.0311709924773666,0.0338940372962822,-0.0976033055780798,0.0352613206233466,0.357762788400662
CASQ2,Calsequestrin-2,Eye measures,X20261.avMSE,29628,-0.0111418766847348,0.00733869956652116,-0.0255257278351163,0.00324197446564665,0.129016029522197
CASQ2,Calsequestrin-2,Eye measures,X20262.Myopia diagnosis,29628,0.0513098136762009,0.0577869445946697,-0.0619525977293518,0.164572225081754,0.374628497104066
CASQ2,Calsequestrin-2,NMR metabolomics,X20280.Glucose-lactate,37529,-0.0160953271040502,0.00481090235857976,-0.0255246957268665,-0.00666595848123384,0.000823375580524249
CASQ2,Calsequestrin-2,NMR metabolomics,X20281.Spectrometer-corrected alanine,37555,-0.00220661612452311,0.00460258492226923,-0.0112276825721708,0.00681445032312458,0.63164093702362
CASQ2,Calsequestrin-2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,31806,0.00357580626019188,0.0212559038243595,-0.0380857652355527,0.0452373777559364,0.866409721817833
CASQ2,Calsequestrin-2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,31804,-0.0129430809862461,0.0405811851969483,-0.0924822039722647,0.0665960419997725,0.749778871269239
CASQ2,Calsequestrin-2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),31802,-0.090390967854289,0.050828351348783,-0.190014536497904,0.00923260078932563,0.075386523964176
CASQ2,Calsequestrin-2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),31802,0.00793014490561392,0.0200400217353544,-0.0313482976956808,0.0472085875069086,0.692326490195741
CASQ2,Calsequestrin-2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),31802,0.00427706595678617,0.0401546509563756,-0.07442604991771,0.0829801818312824,0.915176793917042
CASQ2,Calsequestrin-2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,31808,-0.0521346996285784,0.047485654715156,-0.145206582870284,0.0409371836131274,0.272282260572275
CASQ2,Calsequestrin-2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,31808,0.0147014045560436,0.0322915852045199,-0.0485901024448155,0.0779929115569027,0.648928118632414
CASQ2,Calsequestrin-2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,31808,-0.00455376762575501,0.0353559505433207,-0.0738514306906636,0.0647438954391536,0.897521190362993
CASQ2,Calsequestrin-2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,31808,-0.0122051924515708,0.0575878885573463,-0.125077454023969,0.100667069120828,0.832159507745681
CASQ2,Calsequestrin-2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,31808,-0.115552393905435,0.068899116690922,-0.250594662619642,0.0194898748087719,0.0935606337183152
CASQ2,Calsequestrin-2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,31808,0.015490625739352,0.0368250535254229,-0.0566864791704768,0.0876677306491808,0.674019653818238
CASQ2,Calsequestrin-2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,31808,-0.0427678402668612,0.0702180570477885,-0.180395232080527,0.0948595515468043,0.542495640036607
CASQ2,Calsequestrin-2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,31808,-0.0525385397653992,0.0482817320788241,-0.147170734639894,0.042093655109096,0.276557477488386
CASQ2,Calsequestrin-2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),31808,-0.0721566476864868,0.0594641992672369,-0.188706478250271,0.0443931828772974,0.224997969227655
CASQ2,Calsequestrin-2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),31808,0.0240252720543198,0.0271836479301251,-0.0292546778887253,0.077305221997365,0.376825840710874
CASQ2,Calsequestrin-2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),31808,0.000271460012108396,0.0448185179776003,-0.0875728352239882,0.088115755248205,0.995167509394185
CASQ2,Calsequestrin-2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,31809,0.0190061681814009,0.0661006196355434,-0.110551046304264,0.148563382667066,0.773711656349766
CASQ2,Calsequestrin-2,Diet and food preferences,X20600.Liking for adding salt to foods,33160,0.0402560928378813,0.0378760245634109,-0.033980915306404,0.114493100982167,0.287884751624508
CASQ2,Calsequestrin-2,Diet and food preferences,X20601.Liking for aniseed,33160,0.0685320527406889,0.0381466296439305,-0.00623534136141493,0.143299446842793,0.0724429130983346
CASQ2,Calsequestrin-2,Diet and food preferences,X20602.Liking for apple juice,33160,0.0639278908847184,0.0378038253486078,-0.0101676067985529,0.13802338856799,0.0908644291303022
CASQ2,Calsequestrin-2,Diet and food preferences,X20603.Liking for apples,33160,0.00895926071654563,0.0392286101142346,-0.0679288151073542,0.0858473365404455,0.819351632269397
CASQ2,Calsequestrin-2,Diet and food preferences,X20604.Liking for asparagus,33160,-0.0302282607345088,0.039183469084156,-0.107027860139455,0.046571338670437,0.440458578872161
CASQ2,Calsequestrin-2,Diet and food preferences,X20605.Liking for aubergine,33160,-0.0281036444707833,0.0387485971486828,-0.104050894882202,0.0478436059406349,0.468298801953018
CASQ2,Calsequestrin-2,Diet and food preferences,X20606.Liking for avocados,33160,0.00511183345415039,0.0391476740248596,-0.0716176076345745,0.0818412745428753,0.896111995239674
CASQ2,Calsequestrin-2,Diet and food preferences,X20607.Liking for bacon,33160,0.0270383465376463,0.0394769199512145,-0.0503364165667341,0.104413109642027,0.493415618075866
CASQ2,Calsequestrin-2,Diet and food preferences,X20608.Liking for baked or steamed fish,33160,-0.0464890690367887,0.0396276985836791,-0.1241593582608,0.0311812201872222,0.240769454976854
CASQ2,Calsequestrin-2,Diet and food preferences,X20609.Liking for bananas,33160,0.0219968970216253,0.0392498369438678,-0.0549327833883556,0.0989265774316063,0.575198679484033
CASQ2,Calsequestrin-2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33160,-0.0664550079044186,0.0393735697395469,-0.14362720459393,0.0107171887850933,0.0914840271052647
CASQ2,Calsequestrin-2,Diet and food preferences,X20611.Liking for beef steak,33160,-0.0872586323182339,0.0392172852355738,-0.164124511379959,-0.0103927532565092,0.0261064898389822
CASQ2,Calsequestrin-2,Diet and food preferences,X20612.Liking for beetroot,33160,-0.00833602318313938,0.0396739652412357,-0.0860969950559613,0.0694249486896825,0.833584256100584
CASQ2,Calsequestrin-2,Diet and food preferences,X20613.Liking for bell pepper,33160,0.0257844669189328,0.0386420474989356,-0.0499539461789809,0.101522880016846,0.504620890363119
CASQ2,Calsequestrin-2,Diet and food preferences,X20614.Liking for bicycling,33160,0.00988806179744781,0.038016262433589,-0.0646238125723866,0.0843999361672822,0.79479214570791
CASQ2,Calsequestrin-2,Diet and food preferences,X20615.Liking for biscuits,33160,0.0167921794487815,0.0384777366600413,-0.0586241844048995,0.0922085433024625,0.662548034362349
CASQ2,Calsequestrin-2,Diet and food preferences,X20616.Liking for bitter foods,33160,0.063705159663358,0.0382424901122105,-0.0112501209565746,0.138660440283291,0.0957849918014945
CASQ2,Calsequestrin-2,Diet and food preferences,X20617.Liking for bitter or ale,33160,0.0201191630065936,0.039790082580283,-0.057869398850761,0.0981077248639483,0.613127401295258
CASQ2,Calsequestrin-2,Diet and food preferences,X20618.Liking for black olives,33160,-0.00126802155589272,0.0383595710849865,-0.0764527808824663,0.0739167377706809,0.973630531407595
CASQ2,Calsequestrin-2,Diet and food preferences,X20619.Liking for black pepper,33160,-0.012899416857333,0.0385959962904418,-0.088547569586599,0.0627487358719329,0.738224288677436
CASQ2,Calsequestrin-2,Diet and food preferences,X20620.Liking for blue cheese,33160,0.000576202603189365,0.0380817933091165,-0.0740641122826789,0.0752165174890577,0.987928288933881
CASQ2,Calsequestrin-2,Diet and food preferences,X20621.Liking for bolognese sauce,33160,0.0107298659698611,0.0402241945545292,-0.0681095553570161,0.0895692872967383,0.789666788444923
CASQ2,Calsequestrin-2,Diet and food preferences,X20622.Liking for broad beans,33160,0.0221782573441234,0.0387344983401413,-0.0537413594025535,0.0980978740908004,0.566949876824367
CASQ2,Calsequestrin-2,Diet and food preferences,X20623.Liking for broccoli,33160,-0.0198107690138169,0.0399277155033043,-0.0980690914002934,0.0584475533726596,0.61978993668357
CASQ2,Calsequestrin-2,Diet and food preferences,X20624.Liking for brown rice,33160,0.0631403939610501,0.0389727890176367,-0.0132462725135177,0.139527060435618,0.105243856308583
CASQ2,Calsequestrin-2,Diet and food preferences,X20625.Liking for brussel sprouts,33160,0.0354481452632707,0.0389611782641832,-0.0409157641345284,0.11181205466107,0.362936072784145
CASQ2,Calsequestrin-2,Diet and food preferences,X20626.Liking for burgers (meat),33160,-0.0553974121431356,0.0385146229097998,-0.130886073046343,0.0200912487600719,0.150371451026787
CASQ2,Calsequestrin-2,Diet and food preferences,X20627.Liking for burn of spicy foods,33160,0.0105537263959984,0.0391292367782518,-0.0661395776893751,0.0872470304813719,0.787386225969591
CASQ2,Calsequestrin-2,Diet and food preferences,X20628.Liking for butter on bread,33160,0.0837440304352156,0.0394544255661092,0.00641335632564159,0.16107470454479,0.033819664775974
CASQ2,Calsequestrin-2,Diet and food preferences,X20629.Liking for butternut squash,33160,0.0176499224020794,0.0383080978700281,-0.0574339494231758,0.0927337942273345,0.644999491952116
CASQ2,Calsequestrin-2,Diet and food preferences,X20630.Liking for cabbage,33160,-0.00516886251716215,0.038921236438483,-0.0814544859365889,0.0711167609022646,0.89435214053354
CASQ2,Calsequestrin-2,Diet and food preferences,X20631.Liking for cake,33160,0.0738691158126483,0.0391178121233492,-0.00280179594911609,0.150540027574413,0.0590088089585619
CASQ2,Calsequestrin-2,Diet and food preferences,X20632.Liking for cake icing,33160,0.0796039700953857,0.03969431181341,0.00180311894110208,0.157404821249669,0.0449485345715894
CASQ2,Calsequestrin-2,Diet and food preferences,X20633.Liking for capers,33160,-0.0374543423090046,0.0392771155867471,-0.114437488859029,0.0395288042410198,0.340316714606218
CASQ2,Calsequestrin-2,Diet and food preferences,X20634.Liking for cauliflower,33160,-0.00325171108095077,0.0390852337843049,-0.0798587692981884,0.0733553471362869,0.933698096324239
CASQ2,Calsequestrin-2,Diet and food preferences,X20635.Liking for cereal or granola bar,33160,0.000841376750185254,0.0386210400135418,-0.0748558616763568,0.0765386151767273,0.982619600021526
CASQ2,Calsequestrin-2,Diet and food preferences,X20636.Liking for cheesecake,33160,0.0743232960561604,0.039156065882384,-0.00242259307331223,0.151069185185633,0.0577120526306778
CASQ2,Calsequestrin-2,Diet and food preferences,X20637.Liking for cherries,33160,0.0474975741154584,0.0423380194489582,-0.0354849440044997,0.130480092235416,0.261950488806335
CASQ2,Calsequestrin-2,Diet and food preferences,X20638.Liking for chicken,33160,-0.06945381341275,0.0404675571530245,-0.148770225432678,0.00986259860717792,0.0861457114156088
CASQ2,Calsequestrin-2,Diet and food preferences,X20639.Liking for chilli pepper,33160,-0.0363696732330378,0.0381494695036194,-0.111142633460132,0.0384032869940563,0.340440894891544
CASQ2,Calsequestrin-2,Diet and food preferences,X20640.Liking for chips or french fries,33160,0.0672951105072822,0.0391838342529913,-0.00950520462858075,0.144095425643145,0.0859380056679397
CASQ2,Calsequestrin-2,Diet and food preferences,X20641.Liking for cigarette smoking,33160,-0.0951729127675533,0.063365932029856,-0.219370139546071,0.0290243140109644,0.133144480222107
CASQ2,Calsequestrin-2,Diet and food preferences,X20642.Liking for cod,33160,0.0170352853495493,0.0400508755893375,-0.0614644308055521,0.0955350015046507,0.670598523794698
CASQ2,Calsequestrin-2,Diet and food preferences,X20643.Liking for coffee with sugar,33160,0.027834363379063,0.0437264714290449,-0.0578695206218649,0.113538247379991,0.524430609313388
CASQ2,Calsequestrin-2,Diet and food preferences,X20644.Liking for coffee without sugar,33160,-0.0205726834220256,0.0394822101748275,-0.0979578153646875,0.0568124485206363,0.602336773858397
CASQ2,Calsequestrin-2,Diet and food preferences,X20645.Liking for coriander,33160,-0.0408523786994462,0.0384723302749164,-0.116258146038282,0.03455338863939,0.288326953540476
CASQ2,Calsequestrin-2,Diet and food preferences,X20646.Liking for corn flakes,33160,0.0391395977198985,0.0380061135504808,-0.0353523848390438,0.113631580278841,0.303121389636626
CASQ2,Calsequestrin-2,Diet and food preferences,X20647.Liking for cream,33160,0.0311876725562576,0.0383421604336878,-0.0439629618937705,0.106338307006286,0.416008640942987
CASQ2,Calsequestrin-2,Diet and food preferences,X20648.Liking for croissant,33160,-0.00120521604629946,0.0387828423895707,-0.077219587129858,0.0748091550372591,0.975209633596708
CASQ2,Calsequestrin-2,Diet and food preferences,X20649.Liking for cucumber,33160,0.044527537627381,0.0385107617030191,-0.0309535553105364,0.120008630565298,0.247616300161772
CASQ2,Calsequestrin-2,Diet and food preferences,X20650.Liking for curry,33160,0.0490353353556641,0.0392512646376248,-0.0278971433340804,0.125967814045409,0.211600807156325
CASQ2,Calsequestrin-2,Diet and food preferences,X20651.Liking for dairy products,33160,0.0867277461142446,0.0390655128723875,0.0101593408843651,0.163296151344124,0.0264404351604524
CASQ2,Calsequestrin-2,Diet and food preferences,X20652.Liking for dark chocolate,33160,0.0403736105943272,0.0390338191819841,-0.0361326750023616,0.116879896191016,0.301013537955997
CASQ2,Calsequestrin-2,Diet and food preferences,X20653.Liking for diet fizzy drinks,33160,0.00901529350391411,0.0406384798692868,-0.070636127039888,0.0886667140477163,0.82444262933816
CASQ2,Calsequestrin-2,Diet and food preferences,X20654.Liking for dried fruit,33160,0.039207577450536,0.0383266874506515,-0.035912729952741,0.114327884853813,0.306343988294216
CASQ2,Calsequestrin-2,Diet and food preferences,X20655.Liking for eggs,33160,0.0540535221867131,0.0393141150363343,-0.0230021432845022,0.131109187657928,0.169193558559876
CASQ2,Calsequestrin-2,Diet and food preferences,X20656.Liking for exercising alone,33160,-0.0148994562808482,0.0385777266047485,-0.0905118004261552,0.0607128878644588,0.699343827466265
CASQ2,Calsequestrin-2,Diet and food preferences,X20657.Liking for exercising with others,33160,0.0339969086510166,0.0377111763734115,-0.03991699704087,0.107910814342903,0.367343502029896
CASQ2,Calsequestrin-2,Diet and food preferences,X20658.Liking for extra virgin olive oil,33160,0.0440141421560045,0.0394146452741277,-0.0332385625812857,0.121266846893295,0.264155546488252
CASQ2,Calsequestrin-2,Diet and food preferences,X20659.Liking for fatty foods,33160,0.0105950127490912,0.0386274423724373,-0.0651147743008859,0.0863047997990683,0.783870438514474
CASQ2,Calsequestrin-2,Diet and food preferences,X20660.Liking for fresh tomatoes,33160,0.00200564217199517,0.0428516927701128,-0.0819836756574258,0.0859949600014162,0.962670300684405
CASQ2,Calsequestrin-2,Diet and food preferences,X20661.Liking for fried chicken,33160,-0.00581813061176375,0.0383504544406587,-0.0809850213154548,0.0693487600919273,0.879419533836431
CASQ2,Calsequestrin-2,Diet and food preferences,X20662.Liking for fried or battered fish,33160,0.0444803434324571,0.0388861463679263,-0.0317365034486784,0.120697190313593,0.252712792492278
CASQ2,Calsequestrin-2,Diet and food preferences,X20663.Liking for fruit,33160,-0.0196059805118124,0.0447915650337735,-0.107397447978008,0.0681854869543838,0.661603104254977
CASQ2,Calsequestrin-2,Diet and food preferences,X20664.Liking for garlic,33160,-0.039305437693701,0.0393143506077005,-0.116361564884794,0.037750689497392,0.317448042961368
CASQ2,Calsequestrin-2,Diet and food preferences,X20665.Liking for gherkins,33160,-0.0399632273009494,0.0385227193918398,-0.115467757308955,0.0355413027070565,0.299581237161798
CASQ2,Calsequestrin-2,Diet and food preferences,X20666.Liking for globe artichoke,33160,0.00289814809856299,0.0384634622391921,-0.0724902378902535,0.0782865340873795,0.939939499064459
CASQ2,Calsequestrin-2,Diet and food preferences,X20667.Liking for goat's cheese,33160,0.0781777349792721,0.0379560841968173,0.00378380995351017,0.152571660005034,0.0394579533858436
CASQ2,Calsequestrin-2,Diet and food preferences,X20668.Liking for going to a cafe,33160,0.121214485256804,0.0386799168956837,0.0454018481412635,0.197027122372344,0.00173141746003263
CASQ2,Calsequestrin-2,Diet and food preferences,X20669.Liking for going to the gym,33160,-0.00317114081850827,0.0378572846290129,-0.0773714186913735,0.071029137054357,0.933244670730125
CASQ2,Calsequestrin-2,Diet and food preferences,X20670.Liking for going to the pub,33160,0.0818552972404196,0.0387921694842025,0.00582264505138261,0.157887949429457,0.034878352787067
CASQ2,Calsequestrin-2,Diet and food preferences,X20671.Liking for grapefruit,33160,0.0296685554867257,0.0385395142884999,-0.0458688925187341,0.105206003492185,0.4414265524322
CASQ2,Calsequestrin-2,Diet and food preferences,X20672.Liking for green olives,33160,-0.000828489578792589,0.0387374311534311,-0.0767538546395175,0.0750968754819323,0.982937184249161
CASQ2,Calsequestrin-2,Diet and food preferences,X20673.Liking for haddock,33160,-0.065666550105745,0.0397436033182796,-0.143564012609573,0.012230912398083,0.098518756682289
CASQ2,Calsequestrin-2,Diet and food preferences,X20674.Liking for ham,33160,-0.00906709065192885,0.0390313420374715,-0.0855685210453731,0.0674343397415154,0.816308290421832
CASQ2,Calsequestrin-2,Diet and food preferences,X20675.Liking for hard cheese,33160,0.0724429423441968,0.0399020507726259,-0.00576507717014986,0.150650961858543,0.069478561672907
CASQ2,Calsequestrin-2,Diet and food preferences,X20676.Liking for herring,33160,-0.078308163504969,0.0384726691424436,-0.153714595024158,-0.0029017319857796,0.0418385550382373
CASQ2,Calsequestrin-2,Diet and food preferences,X20677.Liking for honey,33160,0.0476586489453004,0.0389757272557383,-0.0287337764759466,0.124051074366547,0.22144680808066
CASQ2,Calsequestrin-2,Diet and food preferences,X20678.Liking for horseradish or wasabi,33160,-0.0284434295201759,0.038307180127848,-0.103525502570758,0.0466386435304062,0.457798994123909
CASQ2,Calsequestrin-2,Diet and food preferences,X20679.Liking for ice cream,33160,0.092864540418612,0.0395519950561689,0.015342630108521,0.170386450728703,0.0189013400507834
CASQ2,Calsequestrin-2,Diet and food preferences,X20680.Liking for jam,33160,0.0929847450754756,0.0386157345974113,0.0172979052645495,0.168671584886402,0.0160630695701091
CASQ2,Calsequestrin-2,Diet and food preferences,X20681.Liking for kiwi fruit,33160,-0.0348824246454253,0.0382552356548057,-0.109862686528844,0.0400978372379938,0.361881375426917
CASQ2,Calsequestrin-2,Diet and food preferences,X20682.Liking for lager,33160,0.0162294092820863,0.0383024342275863,-0.0588433618039829,0.0913021803681554,0.671782372773544
CASQ2,Calsequestrin-2,Diet and food preferences,X20683.Liking for lamb,33160,-0.0762035763490966,0.0400389683689644,-0.154679954352267,0.00227280165407365,0.0570428305287623
CASQ2,Calsequestrin-2,Diet and food preferences,X20684.Liking for lemons,33160,0.0649081498309396,0.0386337593621593,-0.0108140185188926,0.140630318180772,0.0929759285942595
CASQ2,Calsequestrin-2,Diet and food preferences,X20685.Liking for lentils or beans,33160,-0.0206829034209219,0.0387406162115276,-0.096614511195516,0.0552487043536721,0.593437072362143
CASQ2,Calsequestrin-2,Diet and food preferences,X20686.Liking for liver,33160,-0.106790082883942,0.0386964412825809,-0.182635107797801,-0.0309450579700834,0.00579777509824179
CASQ2,Calsequestrin-2,Diet and food preferences,X20687.Liking for mackerel,33160,-0.0433490427860032,0.0385584042935754,-0.118923515201411,0.0322254296294046,0.260940680245118
CASQ2,Calsequestrin-2,Diet and food preferences,X20688.Liking for marzipan,33160,0.0557818682394692,0.0383174800443456,-0.0193203926474482,0.130884129126387,0.14548919325707
CASQ2,Calsequestrin-2,Diet and food preferences,X20689.Liking for mayonnaise,33160,0.0372095407174243,0.0384239515929185,-0.0381014044046959,0.112520485839545,0.332874342701875
CASQ2,Calsequestrin-2,Diet and food preferences,X20690.Liking for melon,33160,0.0289068394525379,0.040682145312244,-0.0508301653594604,0.108643844264536,0.477380035271107
CASQ2,Calsequestrin-2,Diet and food preferences,X20691.Liking for milk chocolate,33160,0.0689948947361694,0.0394817644612127,-0.00838936360780757,0.146379153080146,0.0805836836998943
CASQ2,Calsequestrin-2,Diet and food preferences,X20692.Liking for mushrooms,33160,0.0915299301057901,0.0402435959312188,0.0126524820806013,0.170407378130979,0.0229663446498818
CASQ2,Calsequestrin-2,Diet and food preferences,X20694.Liking for orange juice,33160,0.0628469254264336,0.0389303762275892,-0.0134566119796413,0.139150462832508,0.106489622414083
CASQ2,Calsequestrin-2,Diet and food preferences,X20695.Liking for oranges,33160,-0.0104682083767075,0.0391844024483403,-0.0872696371754544,0.0663332204220394,0.789358132782646
CASQ2,Calsequestrin-2,Diet and food preferences,X20696.Liking for pasta,33160,0.096132363852597,0.039422819736271,0.0188636371695058,0.173401090535688,0.0147684160976305
CASQ2,Calsequestrin-2,Diet and food preferences,X20697.Liking for pears,33160,0.000165550207406566,0.0384215420199126,-0.0751406721516221,0.0754717725664352,0.996562195509166
CASQ2,Calsequestrin-2,Diet and food preferences,X20698.Liking for pizza,33160,0.053490260501953,0.0379927400509723,-0.0209755099979528,0.127956031001859,0.159194220502287
CASQ2,Calsequestrin-2,Diet and food preferences,X20699.Liking for plain yogurt,33160,0.00894586368667794,0.0388472997463051,-0.06719484381608,0.0850865711894358,0.817877465435258
CASQ2,Calsequestrin-2,Diet and food preferences,X20700.Liking for plums,33160,-0.0022006279024852,0.0395201217114629,-0.0796600664569524,0.075258810651982,0.955595037445045
CASQ2,Calsequestrin-2,Diet and food preferences,X20701.Liking for pollock,33160,-0.030754030070278,0.0385337807935471,-0.10628024042563,0.0447721802850743,0.424830940707397
CASQ2,Calsequestrin-2,Diet and food preferences,X20702.Liking for pork chop,33160,-0.0322618450512136,0.039196762431128,-0.109087499416224,0.0445638093137973,0.410488344695395
CASQ2,Calsequestrin-2,Diet and food preferences,X20703.Liking for porridge,33160,0.0247841012618591,0.0397258793841611,-0.0530786223310966,0.102646824854815,0.532724083501967
CASQ2,Calsequestrin-2,Diet and food preferences,X20704.Liking for potato crisps,33160,0.0338576240368698,0.0381236663897086,-0.040864762086959,0.108580010160699,0.374511575009833
CASQ2,Calsequestrin-2,Diet and food preferences,X20705.Liking for potatoes,33160,0.104604317003934,0.0387472623307362,0.0286596828356906,0.180548951172177,0.00695451901114178
CASQ2,Calsequestrin-2,Diet and food preferences,X20706.Liking for prawns,33160,-0.0546724868764055,0.0400444019221556,-0.13315951464383,0.0238145408910195,0.172195143468434
CASQ2,Calsequestrin-2,Diet and food preferences,X20707.Liking for raw carrots,33160,0.0888057895386124,0.0395732176304405,0.0112422829829491,0.166369296094276,0.024851773748419
CASQ2,Calsequestrin-2,Diet and food preferences,X20708.Liking for red meat,33160,-0.0559850559544705,0.0389699946448893,-0.132366245458453,0.0203961335495126,0.15086208936339
CASQ2,Calsequestrin-2,Diet and food preferences,X20709.Liking for red wine,33160,-0.0465916923074127,0.0388155909361717,-0.122670250542309,0.0294868659274837,0.230042148669457
CASQ2,Calsequestrin-2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33160,0.0443072867697426,0.0405207361466896,-0.035113356077769,0.123727929617254,0.274227763472709
CASQ2,Calsequestrin-2,Diet and food preferences,X20711.Liking for roast chicken,33160,-0.070276545429678,0.0411714470539092,-0.15097258165534,0.010419490795984,0.0878718024571678
CASQ2,Calsequestrin-2,Diet and food preferences,X20712.Liking for salad dressing,33160,0.0840527297589778,0.0381157744007335,0.00934581193354013,0.158759647584415,0.0274664521717598
CASQ2,Calsequestrin-2,Diet and food preferences,X20713.Liking for salad leaves,33160,0.052454924684643,0.0401054732966467,-0.0261518029767845,0.131061652346071,0.190933534287696
CASQ2,Calsequestrin-2,Diet and food preferences,X20714.Liking for salami,33160,0.0248783719316559,0.0391437021476255,-0.05184328427769,0.101600028141002,0.525076625298623
CASQ2,Calsequestrin-2,Diet and food preferences,X20715.Liking for salmon,33160,-0.0360094571285848,0.0416533887981007,-0.117650099172862,0.0456311849156926,0.387335766471603
CASQ2,Calsequestrin-2,Diet and food preferences,X20716.Liking for salty foods,33160,0.0455847107046971,0.038135494466736,-0.0291608584501055,0.1203302798595,0.231988556383022
CASQ2,Calsequestrin-2,Diet and food preferences,X20717.Liking for salty pretzels,33160,-0.0048992431845487,0.0382146118921042,-0.0797998824930728,0.0700013961239755,0.897990972820275
CASQ2,Calsequestrin-2,Diet and food preferences,X20718.Liking for sardines,33160,-0.0641268040805319,0.0386250414413504,-0.139831885305579,0.011578277144515,0.0969024031622555
CASQ2,Calsequestrin-2,Diet and food preferences,X20719.Liking for sausages (meat),33160,-0.00509988420775535,0.0391097867623244,-0.0817550662619112,0.0715552978464005,0.896253628772862
CASQ2,Calsequestrin-2,Diet and food preferences,X20720.Liking for savoury biscuits,33160,0.0435148875055208,0.0385806295135825,-0.0321031463411009,0.119132921352142,0.259395500038042
CASQ2,Calsequestrin-2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33160,-0.0796778175993523,0.0393335375768956,-0.156771551250068,-0.00258408394863702,0.0428263407790165
CASQ2,Calsequestrin-2,Diet and food preferences,X20722.Liking for skimmed milk,33160,0.0235662407191305,0.0379215028092366,-0.0507599047869733,0.0978923862252343,0.534321206225672
CASQ2,Calsequestrin-2,Diet and food preferences,X20723.Liking for smoked fish,33160,-0.0825694047729115,0.038874928424224,-0.15876426448439,-0.00637454506143248,0.0337003071346827
CASQ2,Calsequestrin-2,Diet and food preferences,X20724.Liking for soft cheese,33160,0.0449493228139266,0.0386041103141495,-0.0307147334018064,0.12061337902966,0.244307553955715
CASQ2,Calsequestrin-2,Diet and food preferences,X20725.Liking for soy sauce,33160,0.0104514242030002,0.0384988154068249,-0.0650062539943766,0.085909102400377,0.786033000103112
CASQ2,Calsequestrin-2,Diet and food preferences,X20726.Liking for soya milk,33160,0.0483770907350687,0.0382540264192949,-0.0266008010467493,0.123354982516887,0.206038798206352
CASQ2,Calsequestrin-2,Diet and food preferences,X20727.Liking for spicy foods,33160,-0.0403491198802246,0.0384840602359764,-0.115777877942738,0.0350796381822891,0.294454389677286
CASQ2,Calsequestrin-2,Diet and food preferences,X20728.Liking for spinach,33160,-0.00813557325517481,0.0393332875952737,-0.0852288169419113,0.0689576704315617,0.836142118270349
CASQ2,Calsequestrin-2,Diet and food preferences,X20729.Liking for spirits,33160,0.0330904021294077,0.0384653404866283,-0.0423016652243837,0.108482469483199,0.389666460261287
CASQ2,Calsequestrin-2,Diet and food preferences,X20730.Liking for strawberries,33160,-0.00994991094158804,0.0440419973798041,-0.0962722258060041,0.076372403922828,0.821269958211002
CASQ2,Calsequestrin-2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33160,0.00215064452037124,0.0395560791224463,-0.0753792705596235,0.079680559600366,0.956642021336678
CASQ2,Calsequestrin-2,Diet and food preferences,X20732.Liking for sweet foods,33160,0.0581239109872919,0.0383939176734083,-0.0171281676525884,0.133375989627172,0.130091769087416
CASQ2,Calsequestrin-2,Diet and food preferences,X20733.Liking for taking the stairs,33160,0.0328141361116786,0.0387808696994036,-0.0431963684991524,0.10882464072251,0.397496614004237
CASQ2,Calsequestrin-2,Diet and food preferences,X20734.Liking for tea with sugar,33160,0.00703816967021211,0.0513101808933155,-0.0935297848806862,0.10760612422111,0.890900334730012
CASQ2,Calsequestrin-2,Diet and food preferences,X20735.Liking for tea without sugar,33160,-0.0898808063176041,0.0407230213679123,-0.169697928198712,-0.0100636844364961,0.0273313292114064
CASQ2,Calsequestrin-2,Diet and food preferences,X20736.Liking for tomato ketchup,33160,0.0613508930721323,0.038473077413685,-0.0140563386586902,0.136758124802955,0.110828015198589
CASQ2,Calsequestrin-2,Diet and food preferences,X20737.Liking for tinned tuna,33160,0.00379891179478461,0.039327520301759,-0.073283027996663,0.0808808515862322,0.923048839594433
CASQ2,Calsequestrin-2,Diet and food preferences,X20738.Liking for turnip (white),33160,-0.00570646164671761,0.0375949957587463,-0.0793926533338604,0.0679797300404252,0.879357825787996
CASQ2,Calsequestrin-2,Diet and food preferences,X20739.Liking for vegetables,33160,0.0318713307351127,0.0451076042058401,-0.056539573508334,0.120282234978559,0.479857473556026
CASQ2,Calsequestrin-2,Diet and food preferences,X20740.Liking for vinegar,33160,0.056531058032383,0.038423657419856,-0.0187793105105348,0.131841426575301,0.141257918244364
CASQ2,Calsequestrin-2,Diet and food preferences,X20741.Liking for watching television,33160,0.0607091379754244,0.0391754364745584,-0.01607471751471,0.137492993465559,0.121256265780814
CASQ2,Calsequestrin-2,Diet and food preferences,X20742.Liking for whisky,33160,0.0426730480764328,0.0412325550603089,-0.0381427598417727,0.123488855994638,0.300727655202829
CASQ2,Calsequestrin-2,Diet and food preferences,X20743.Liking for white bread,33160,0.0255607098856226,0.0385690363181092,-0.0500346012978714,0.101156021069117,0.507523501588878
CASQ2,Calsequestrin-2,Diet and food preferences,X20744.Liking for white rice,33160,0.105097696225368,0.0384406763076896,0.0297539706622963,0.18044142178844,0.00626922483841268
CASQ2,Calsequestrin-2,Diet and food preferences,X20745.Liking for white wine,33160,-0.0133960833594412,0.0392945747888266,-0.0904134499455413,0.0636212832266589,0.733176314990305
CASQ2,Calsequestrin-2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33160,-0.00436062409190608,0.039101309263997,-0.0809991902493402,0.072277942065528,0.911205645235001
CASQ2,Calsequestrin-2,Diet and food preferences,X20747.Liking for whole milk,33160,-0.0212903443844923,0.0379356441969714,-0.0956442070105563,0.0530635182415716,0.574660191342979
CASQ2,Calsequestrin-2,Diet and food preferences,X20748.Liking for wholemeal bread,33160,0.0634031249955828,0.042302263668648,-0.0195093117949672,0.146315561786133,0.133958791889759
CASQ2,Calsequestrin-2,Diet and food preferences,X20749.Liking for working up a sweat,33160,0.0536037507090781,0.0386655333738977,-0.0221806947037614,0.129388196121918,0.16567725556036
CASQ2,Calsequestrin-2,Physical measures,X21001.Body mass index (BMI),47803,-0.0103783766226256,0.0129606316893206,-0.0357812147336941,0.0150244614884428,0.423277800219262
CASQ2,Calsequestrin-2,Physical measures,X21002.Weight,47810,0.00358144206173217,0.00807684928720123,-0.0122491825411822,0.0194120666646466,0.657465582252171
CASQ2,Calsequestrin-2,Physical measures,X21021.Pulse wave Arterial Stiffness index,32251,0.00408694790041261,0.00586966400644963,-0.00741759355222867,0.0155914893530539,0.486272299110293
CASQ2,Calsequestrin-2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,32688,0.0458185434799603,0.0409091355588677,-0.0343633622154205,0.126000449175341,0.262743195198898
CASQ2,Calsequestrin-2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,32701,0.0162848331334521,0.0421727564787104,-0.0663737695648203,0.0989434358317245,0.699398648123697
CASQ2,Calsequestrin-2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,32702,0.00529862217765313,0.0426892463490488,-0.0783723006664825,0.0889695450217888,0.901222677247827
CASQ2,Calsequestrin-2,Health and medical history,X21040.Satisfaction with bowel habits,32654,-0.0164468636421423,0.0393332069442564,-0.0935399492528848,0.0606462219686002,0.675854298069986
CASQ2,Calsequestrin-2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32639,-0.0229783260916873,0.0411097493106248,-0.103553434740512,0.0575967825571374,0.576210622700178
CASQ2,Calsequestrin-2,Health and medical history,X21042.Greatest number of times bowels opened per day,32653,-0.064271444465097,0.0423078217676879,-0.147194775129765,0.0186518861995713,0.128766169732201
CASQ2,Calsequestrin-2,Health and medical history,X21043.Least number of times bowels opened per week,32572,-0.0410834147187291,0.0418554403891308,-0.123120077881425,0.0409532484439674,0.326348397879492
CASQ2,Calsequestrin-2,Health and medical history,X21044.Average number of times bowels opened per day,32621,-0.0601576502183832,0.0487138550245095,-0.155636806066422,0.0353215056296555,0.216896318008983
CASQ2,Calsequestrin-2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,32704,0.0618060031151819,0.0424669714484266,-0.0214292609237342,0.145041267154098,0.145599383377981
CASQ2,Calsequestrin-2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,32700,0.0468722375227955,0.0431605945323974,-0.0377225277607034,0.131467002806294,0.277512457632876
CASQ2,Calsequestrin-2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32702,0.0234711897663293,0.0500797262989968,-0.0746850737797045,0.121627453312363,0.639313288403312
CASQ2,Calsequestrin-2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,32701,-0.0585176887829292,0.0445575259815238,-0.145850439706716,0.0288150621408574,0.189116219888373
CASQ2,Calsequestrin-2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,32698,-0.064476670343996,0.0647237893898546,-0.191335297548111,0.0623819568601191,0.319190985122454
CASQ2,Calsequestrin-2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,32699,0.0302845682190282,0.0493329632360757,-0.0664080397236801,0.126977176161737,0.539310908544947
CASQ2,Calsequestrin-2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,32699,-0.0680114216055766,0.118820609644019,-0.300899816507853,0.1648769732967,0.567075144473817
CASQ2,Calsequestrin-2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,32704,0.0098437648950355,0.0469569226740838,-0.0821918035461687,0.10187933333624,0.833958560460595
CASQ2,Calsequestrin-2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,32702,0.0476206771696619,0.0496512897587832,-0.0496958507575531,0.144937205096877,0.33753521029153
CASQ2,Calsequestrin-2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32471,-0.102062589689249,0.0427722370774675,-0.185896174361085,-0.0182290050174126,0.0170471198904754
CASQ2,Calsequestrin-2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,32700,0.0477482084609215,0.0439370897786751,-0.0383684875052817,0.133864904427125,0.277183336321444
CASQ2,Calsequestrin-2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,32701,0.0836341022639755,0.0599604447237372,-0.0338883693945494,0.2011565739225,0.163107310939605
CASQ2,Calsequestrin-2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,32704,0.0234989344592051,0.0427453802641616,-0.0602820108585516,0.107279879776962,0.582511166303123
CASQ2,Calsequestrin-2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,32703,0.010231670144112,0.0426921819322547,-0.0734450064431072,0.0939083467313311,0.810598677826951
CASQ2,Calsequestrin-2,Working and living environment,X21100.Water hardness (USGS classification),47686,-0.0151147704581595,0.024200831999971,-0.0625484011781025,0.0323188602617836,0.532268757394588
CASQ2,Calsequestrin-2,Lifestyle factors,X2139.Age first had sexual intercourse,44566,0.000231605340107032,0.00415779966294879,-0.00791768199927259,0.00838089267948665,0.955578306495856
CASQ2,Calsequestrin-2,Health and medical history,X2149.Lifetime number of sexual partners,43284,-0.0228619680330216,0.0272147393835442,-0.0762028572247683,0.030478921158725,0.400886357696966
CASQ2,Calsequestrin-2,Physical activities,X22032.IPAQ activity group,42506,0.0271596071745777,0.0278185049058007,-0.0273646624407917,0.0816838767899471,0.328921763763925
CASQ2,Calsequestrin-2,Physical activities,X22033.Summed days activity,43089,0.00386435561081829,0.00388357916713212,-0.00374745955676066,0.0114761707783972,0.319724845545739
CASQ2,Calsequestrin-2,Physical activities,X22034.Summed minutes activity,42506,-0.00305922562782112,0.00390239919713624,-0.0107079280542082,0.00458947679856591,0.433088789634772
CASQ2,Calsequestrin-2,Physical activities,X22037.MET minutes per week for walking,41621,0.00130850994071991,0.00397911164645563,-0.00649054888633312,0.00910756876777294,0.742277054069176
CASQ2,Calsequestrin-2,Physical activities,X22038.MET minutes per week for moderate activity,42506,-0.00212912772017674,0.00385888166702793,-0.00969253578755148,0.005434280347198,0.581128295418175
CASQ2,Calsequestrin-2,Physical activities,X22039.MET minutes per week for vigorous activity,42506,0.0541582874088209,0.0276579254190344,-5.12464124865081e-05,0.108367821230128,0.0502281285125149
CASQ2,Calsequestrin-2,Physical activities,X22040.Summed MET minutes per week for all activity,41621,0.00130297002081789,0.00405067889920703,-0.00663636062162788,0.00924230066326366,0.747708841750554
CASQ2,Calsequestrin-2,Eye measures,X2217.Age started wearing glasses or contact lenses,44605,0.00515584849807614,0.00373210309536209,-0.00215907356883356,0.0124707705649858,0.167144868324469
CASQ2,Calsequestrin-2,Working and living environment,X22501.Year ended full time education,30110,0.0222650881030932,0.0172660074691774,-0.0115762865364945,0.056106462742681,0.197265527040468
CASQ2,Calsequestrin-2,Lifestyle factors,X22506.Tobacco smoking,30080,-0.0660375963650193,0.106349753649773,-0.274483113518575,0.142407920788536,0.534659428636325
CASQ2,Calsequestrin-2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,46316,-0.0638572926599665,0.0607638378232895,-0.182954414793614,0.0552398294736808,0.293311785727676
CASQ2,Calsequestrin-2,Physical measures,X23098.Weight,47454,0.00380607492523673,0.00815766039978032,-0.0121829394583327,0.0197950893088062,0.640815893503607
CASQ2,Calsequestrin-2,Physical measures,X23099.Body fat percentage,47455,0.00163951935465782,0.00836777197493114,-0.0147613137162072,0.0180403524255229,0.844664648062488
CASQ2,Calsequestrin-2,Physical measures,X23100.Whole body fat mass,47448,0.00416912609412481,0.00802652331916816,-0.0115628596114448,0.0199011117996944,0.603473811369967
CASQ2,Calsequestrin-2,Physical measures,X23101.Whole body fat-free mass,47454,6.95214558827492e-05,0.00669205132905588,-0.0130468991490668,0.0131859420608323,0.991711286583492
CASQ2,Calsequestrin-2,Physical measures,X23102.Whole body water mass,47454,-0.000831221301550867,0.00671729480476961,-0.0139971191188993,0.0123346765157976,0.901519481119861
CASQ2,Calsequestrin-2,Physical measures,X23104.Body mass index (BMI),47454,-0.0105419957475175,0.013170349378611,-0.0363558805295951,0.01527188903456,0.423467641614067
CASQ2,Calsequestrin-2,Physical measures,X23105.Basal metabolic rate,47452,0.00101368765798792,0.00729738385912107,-0.0132891847058894,0.0153165600218652,0.889521611435844
CASQ2,Calsequestrin-2,Physical measures,X23106.Impedance of whole body,47448,0.00250813306347211,0.00547989733301931,-0.00823246570924574,0.01324873183619,0.647174403166823
CASQ2,Calsequestrin-2,Physical measures,X23107.Impedance of leg (right),47451,-0.00272422770676546,0.00449739477069078,-0.0115391214573194,0.00609066604378846,0.544696969242891
CASQ2,Calsequestrin-2,Physical measures,X23108.Impedance of leg (left),47450,0.00253913224256418,0.00444936461402349,-0.00618162240092186,0.0112598868860502,0.568226901429928
CASQ2,Calsequestrin-2,Physical measures,X23109.Impedance of arm (right),47443,0.00437260353879575,0.005481502110448,-0.00637114059768234,0.0151163476752738,0.42505185708019
CASQ2,Calsequestrin-2,Physical measures,X23110.Impedance of arm (left),47449,0.00269610605501293,0.00549823573776844,-0.0080804359910132,0.0134726481010391,0.623884989790305
CASQ2,Calsequestrin-2,Physical measures,X23111.Leg fat percentage (right),47450,-0.0126061822435875,0.0131831019141538,-0.0384450619953289,0.013232697508154,0.338962086222153
CASQ2,Calsequestrin-2,Physical measures,X23112.Leg fat mass (right),47449,0.00241342321116919,0.0151313514772056,-0.0272440256841538,0.0320708721064922,0.873277782950835
CASQ2,Calsequestrin-2,Physical measures,X23113.Leg fat-free mass (right),47449,0.004811776963001,0.00681586806471247,-0.00854732444383545,0.0181708783698374,0.480215899329066
CASQ2,Calsequestrin-2,Physical measures,X23114.Leg predicted mass (right),47448,0.00445562046677015,0.00684302851221436,-0.00895671541716999,0.0178679563507103,0.514976689294489
CASQ2,Calsequestrin-2,Physical measures,X23115.Leg fat percentage (left),47445,0.00422688338702998,0.0136227012621427,-0.0224736110867697,0.0309273778608296,0.756349085046407
CASQ2,Calsequestrin-2,Physical measures,X23116.Leg fat mass (left),47445,0.0125832487594419,0.0152064209292427,-0.0172213362618737,0.0423878337807575,0.407964715409141
CASQ2,Calsequestrin-2,Physical measures,X23117.Leg fat-free mass (left),47443,-0.000105378236389772,0.00698711703550742,-0.0138001276259843,0.0135893711532048,0.987967059130482
CASQ2,Calsequestrin-2,Physical measures,X23118.Leg predicted mass (left),47442,-0.00113700202582395,0.00701496751986305,-0.0148863383647555,0.0126123343131076,0.871242473804511
CASQ2,Calsequestrin-2,Physical measures,X23119.Arm fat percentage (right),47442,0.00509909355272319,0.00926935305038769,-0.0130688384260367,0.0232670255314831,0.582254470586736
CASQ2,Calsequestrin-2,Physical measures,X23120.Arm fat mass (right),47439,-0.00115626599247888,0.00837133707337943,-0.0175640866563026,0.0152515546713448,0.89014519240574
CASQ2,Calsequestrin-2,Physical measures,X23121.Arm fat-free mass (right),47441,-0.00326487513687708,0.00651614707603057,-0.016036523405897,0.00950677313214283,0.616345090201425
CASQ2,Calsequestrin-2,Physical measures,X23122.Arm predicted mass (right),47440,-0.00333716930497692,0.00651058450959234,-0.0160979149437779,0.00942357633382405,0.608252876361571
CASQ2,Calsequestrin-2,Physical measures,X23123.Arm fat percentage (left),47438,0.00329888723525361,0.0104081052477571,-0.0171009990503503,0.0236987735208576,0.751281629800013
CASQ2,Calsequestrin-2,Physical measures,X23124.Arm fat mass (left),47438,0.00150190559803516,0.00858523756504179,-0.0153251600294467,0.0183289712255171,0.861127941479769
CASQ2,Calsequestrin-2,Physical measures,X23125.Arm fat-free mass (left),47438,-0.00473187008960935,0.00702316890292177,-0.018497281139336,0.00903354096011732,0.500476133369276
CASQ2,Calsequestrin-2,Physical measures,X23126.Arm predicted mass (left),47436,-0.00391582333813655,0.00703499673408489,-0.0177044169369429,0.00987277026066984,0.577792169729278
CASQ2,Calsequestrin-2,Physical measures,X23127.Trunk fat percentage,47435,0.00107742438492192,0.0052838470023875,-0.00927891573975759,0.0114337645096014,0.838426354167952
CASQ2,Calsequestrin-2,Physical measures,X23128.Trunk fat mass,47431,0.00338397340763173,0.00609732082358359,-0.00856677540659211,0.0153347222218556,0.57890451041136
CASQ2,Calsequestrin-2,Physical measures,X23129.Trunk fat-free mass,47426,0.000146062816051189,0.00624542727698359,-0.0120949746468366,0.012387100278939,0.981341648998014
CASQ2,Calsequestrin-2,Physical measures,X23130.Trunk predicted mass,47423,-0.000335512596024579,0.00625873403120446,-0.0126026312971853,0.0119316061051362,0.957248663932155
CASQ2,Calsequestrin-2,NMR metabolomics,X23400.Total Cholesterol,37562,-0.00758510413755455,0.00477261488411557,-0.0169394293104211,0.00176922103531196,0.112017392555328
CASQ2,Calsequestrin-2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,37562,-0.00374144579645624,0.00461546397870964,-0.0127877551947271,0.00530486360181466,0.417591375882759
CASQ2,Calsequestrin-2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",37562,-0.00261805582880144,0.00461061103365304,-0.0116548534547614,0.00641874179715852,0.570158280442117
CASQ2,Calsequestrin-2,NMR metabolomics,X23403.VLDL Cholesterol,37562,-0.00117805307149067,0.00452154279455438,-0.0100402769488173,0.00768417080583591,0.794449597878209
CASQ2,Calsequestrin-2,NMR metabolomics,X23404.Clinical LDL Cholesterol,37562,-0.00325516830908605,0.00461688789603539,-0.0123042685853154,0.00579393196714332,0.480787401011567
CASQ2,Calsequestrin-2,NMR metabolomics,X23405.LDL Cholesterol,37562,-0.00465955160219283,0.00461564825264302,-0.0137062221773731,0.00438711897298749,0.312747853192813
CASQ2,Calsequestrin-2,NMR metabolomics,X23406.HDL Cholesterol,37562,-0.0155405819063599,0.00532244078640088,-0.0259725658477056,-0.00510859796501417,0.00350827174454207
CASQ2,Calsequestrin-2,NMR metabolomics,X23407.Total Triglycerides,37562,-0.00404841449306226,0.00488515427406723,-0.013623316870234,0.00552648788410952,0.407279176008505
CASQ2,Calsequestrin-2,NMR metabolomics,X23408.Triglycerides in VLDL,37562,-0.00357553675477892,0.00489062216306211,-0.0131611561943807,0.00601008268482281,0.464730779465145
CASQ2,Calsequestrin-2,NMR metabolomics,X23409.Triglycerides in LDL,37562,-0.00649648699093994,0.00487153487874907,-0.0160446953532881,0.00305172137140823,0.182371070438376
CASQ2,Calsequestrin-2,NMR metabolomics,X23410.Triglycerides in HDL,37562,-0.00426736585192077,0.00459160768225242,-0.0132669169091355,0.00473218520529398,0.352707325594556
CASQ2,Calsequestrin-2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,37562,-0.0117911521108421,0.00485934568446408,-0.0213154696523917,-0.0022668345692925,0.0152590772520615
CASQ2,Calsequestrin-2,NMR metabolomics,X23412.Phospholipids in VLDL,37562,-0.00221356934407039,0.00465751395382598,-0.0113422966935693,0.00691515800542853,0.634603576012023
CASQ2,Calsequestrin-2,NMR metabolomics,X23413.Phospholipids in LDL,37562,-0.00364775479181654,0.00458183943604489,-0.0126281600864645,0.00533265050283144,0.425968996391691
CASQ2,Calsequestrin-2,NMR metabolomics,X23414.Phospholipids in HDL,37562,-0.0154561678468641,0.00514790204905717,-0.0255460558630161,-0.00536627983071203,0.00268346513003316
CASQ2,Calsequestrin-2,NMR metabolomics,X23415.Total Esterified Cholesterol,37562,-0.00801430914971837,0.00478833371985179,-0.0173994432406279,0.00137082494119114,0.0942103495704778
CASQ2,Calsequestrin-2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,37562,-0.000361727818036183,0.00449250080256198,-0.00916702939105767,0.0084435737549853,0.935826396804793
CASQ2,Calsequestrin-2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,37562,-0.00499812600359186,0.00460600517796318,-0.0140258961523997,0.00402964414521598,0.277882919640676
CASQ2,Calsequestrin-2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,37562,-0.0153192053402712,0.00528661348368145,-0.0256809677682869,-0.00495744291225557,0.00376490442585765
CASQ2,Calsequestrin-2,NMR metabolomics,X23419.Total Free Cholesterol,37562,-0.00640702418051299,0.00473151755044557,-0.0156807985793863,0.00286675021836033,0.175722674511983
CASQ2,Calsequestrin-2,NMR metabolomics,X23420.Free Cholesterol in VLDL,37562,-0.00222700812555051,0.00460318809488222,-0.0112492567915197,0.00679524054041864,0.628538096747529
CASQ2,Calsequestrin-2,NMR metabolomics,X23421.Free Cholesterol in LDL,37562,-0.00363050641636086,0.00465419713121997,-0.012752732793552,0.00549171996083028,0.435375534773557
CASQ2,Calsequestrin-2,NMR metabolomics,X23422.Free Cholesterol in HDL,37562,-0.0151568972658515,0.00534568677006823,-0.0256344433351853,-0.00467935119651782,0.00458454530232068
CASQ2,Calsequestrin-2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,37562,-0.00929600347820321,0.00475312472014579,-0.0186121279296889,2.01209732825346e-05,0.0505138413199325
CASQ2,Calsequestrin-2,NMR metabolomics,X23424.Total Lipids in VLDL,37562,-0.00288650630218907,0.00475091624234306,-0.0121983021371815,0.00642528953280333,0.543484326601356
CASQ2,Calsequestrin-2,NMR metabolomics,X23425.Total Lipids in LDL,37562,-0.00468594452761144,0.00460664700026951,-0.0137149726481397,0.00434308359291681,0.309070542553289
CASQ2,Calsequestrin-2,NMR metabolomics,X23426.Total Lipids in HDL,37562,-0.0159375504575226,0.00521448299146116,-0.0261579371207865,-0.00571716379425872,0.00224462147682115
CASQ2,Calsequestrin-2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,37562,-0.0151444424015625,0.00487729438429383,-0.0247039393947784,-0.00558494540834662,0.00190626039003814
CASQ2,Calsequestrin-2,NMR metabolomics,X23428.Concentration of VLDL Particles,37562,-0.0015481793574998,0.0045879308888353,-0.010540523899617,0.00744416518461738,0.735786044590106
CASQ2,Calsequestrin-2,NMR metabolomics,X23429.Concentration of LDL Particles,37562,-0.00229082592884612,0.00456937907800715,-0.0112468089217401,0.0066651570640479,0.616138209710612
CASQ2,Calsequestrin-2,NMR metabolomics,X23430.Concentration of HDL Particles,37562,-0.0155600731601453,0.00488364282988599,-0.0251320131067219,-0.00598813321356881,0.00144512147828984
CASQ2,Calsequestrin-2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,37562,-0.00479015480717532,0.00515988308812386,-0.0149035256598981,0.00532321604554743,0.353245414056665
CASQ2,Calsequestrin-2,NMR metabolomics,X23432.Average Diameter for LDL Particles,37562,0.00169178517076902,0.0046983403990448,-0.00751696201135878,0.0109005323528968,0.718792033313356
CASQ2,Calsequestrin-2,NMR metabolomics,X23433.Average Diameter for HDL Particles,37562,-0.00918071141430837,0.00558740488909401,-0.0201320249969326,0.00177060216831588,0.100384506290867
CASQ2,Calsequestrin-2,NMR metabolomics,X23434.Phosphoglycerides,37549,-0.0135945081768394,0.00488039021895785,-0.0231600730059968,-0.00402894334768204,0.00535159148037845
CASQ2,Calsequestrin-2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,37549,0.00170314105846137,0.00518327190139076,-0.00845607186826453,0.0118623539851873,0.742475273503582
CASQ2,Calsequestrin-2,NMR metabolomics,X23436.Total Cholines,37549,-0.0131519253643956,0.00489609393076396,-0.0227482694686929,-0.00355558126009821,0.0072359290119955
CASQ2,Calsequestrin-2,NMR metabolomics,X23437.Phosphatidylcholines,37549,-0.0136526367686641,0.00489760557376336,-0.0232519436932403,-0.00405332984408796,0.00531741820692406
CASQ2,Calsequestrin-2,NMR metabolomics,X23438.Sphingomyelins,37548,-0.00936173856816576,0.00492751597998491,-0.0190196698889362,0.000296192752604675,0.0574694950949338
CASQ2,Calsequestrin-2,NMR metabolomics,X23439.Apolipoprotein B,37562,-0.00196842969170815,0.00456888928961932,-0.010923452699362,0.00698659331594571,0.666596661166956
CASQ2,Calsequestrin-2,NMR metabolomics,X23440.Apolipoprotein A1,37562,-0.016220292857521,0.00504834210203371,-0.0261150433775071,-0.0063255423375349,0.00131676565082798
CASQ2,Calsequestrin-2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,37562,0.00659474526499075,0.00460180107265406,-0.00242478483741121,0.0156142753673927,0.151859058952113
CASQ2,Calsequestrin-2,NMR metabolomics,X23442.Total Fatty Acids,37549,-0.0106543232539455,0.00489576160996981,-0.0202500160094863,-0.00105863049840466,0.0295555712609343
CASQ2,Calsequestrin-2,NMR metabolomics,X23443.Degree of Unsaturation,37549,0.00218460425299705,0.00510145930764446,-0.00781425598998609,0.0121834644959802,0.668489814779683
CASQ2,Calsequestrin-2,NMR metabolomics,X23444.Omega-3 Fatty Acids,37549,-0.00505729447306915,0.0047751370604815,-0.0144165631116129,0.00430197416547459,0.289578843971025
CASQ2,Calsequestrin-2,NMR metabolomics,X23445.Omega-6 Fatty Acids,37549,-0.0087931875428817,0.00474103617362126,-0.0180856184431794,0.000499243357415977,0.0636619071553334
CASQ2,Calsequestrin-2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,37549,-0.00907769387060513,0.00478533801826798,-0.0184569563864104,0.000301568645200104,0.0578524631283677
CASQ2,Calsequestrin-2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,37549,-0.00947451539268536,0.00501899095208137,-0.0193117376587649,0.00036270687339412,0.0590838766843165
CASQ2,Calsequestrin-2,NMR metabolomics,X23448.Saturated Fatty Acids,37549,-0.0112327950078504,0.00499005877541712,-0.021013310207668,-0.00145227980803287,0.0243998573391567
CASQ2,Calsequestrin-2,NMR metabolomics,X23449.Linoleic Acid,37549,-0.00698755685417456,0.00469313314970632,-0.016186097827599,0.00221098411924983,0.136540536342945
CASQ2,Calsequestrin-2,NMR metabolomics,X23450.Docosahexaenoic Acid,37549,-0.00347670065934933,0.00501786944456706,-0.0133117247707008,0.00635832345200211,0.488407243464906
CASQ2,Calsequestrin-2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,37549,-0.000423429773281093,0.0047528632096274,-0.00973904166415079,0.00889218211758861,0.929012216703883
CASQ2,Calsequestrin-2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,37549,0.00699802834728372,0.0053497453030919,-0.00348747244677639,0.0174835291413438,0.190860670043539
CASQ2,Calsequestrin-2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,37549,0.00649997878878525,0.00535865754876463,-0.00400299000679342,0.0170029475843639,0.22515689308504
CASQ2,Calsequestrin-2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,37549,-0.00398199166455591,0.00528626204282675,-0.0143430652684963,0.00637908193938452,0.451300193509792
CASQ2,Calsequestrin-2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,37549,-0.006576110969303,0.00496622736956703,-0.0163099166136544,0.00315769467504839,0.185470925247159
CASQ2,Calsequestrin-2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,37549,0.00390674027628397,0.0051375379086274,-0.00616283402462574,0.0139763145771937,0.4470110152528
CASQ2,Calsequestrin-2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,37549,0.0028998755183876,0.00506841572845242,-0.00703421930937915,0.0128339703461543,0.567232655898437
CASQ2,Calsequestrin-2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,37549,0.00523173578733191,0.00534026365796214,-0.00523518098227389,0.0156986525569377,0.327263465206667
CASQ2,Calsequestrin-2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,37547,0.00196519244751536,0.00473666406837716,-0.00731866912650388,0.0112490540215346,0.678229553195147
CASQ2,Calsequestrin-2,NMR metabolomics,X23460.Alanine,37555,0.00080611182165429,0.00458620632010705,-0.00818285256575554,0.00979507620906411,0.860478325490795
CASQ2,Calsequestrin-2,NMR metabolomics,X23461.Glutamine,37519,-0.00326527697849869,0.00463485306603411,-0.0123495889879255,0.00581903503092817,0.481130917117959
CASQ2,Calsequestrin-2,NMR metabolomics,X23462.Glycine,37544,-0.00121489771643666,0.00439608711718758,-0.00983122846612432,0.00740143303325099,0.782276797897191
CASQ2,Calsequestrin-2,NMR metabolomics,X23463.Histidine,37545,-0.00209809412176342,0.00449292432585987,-0.0109042258004488,0.00670803755692193,0.640523817710958
CASQ2,Calsequestrin-2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),37552,0.002299546753396,0.00460619706670929,-0.00672859949735419,0.0113276930041462,0.617626511779768
CASQ2,Calsequestrin-2,NMR metabolomics,X23465.Isoleucine,37558,0.000380635969399707,0.00451394590900281,-0.00846669801224581,0.00922796995104522,0.932799767736322
CASQ2,Calsequestrin-2,NMR metabolomics,X23466.Leucine,37559,0.00157879270287201,0.00459949111248082,-0.00743620987759039,0.0105937952833344,0.731413055431557
CASQ2,Calsequestrin-2,NMR metabolomics,X23467.Valine,37552,0.00311884148463441,0.00464873619269242,-0.00599268145304272,0.0122303644223115,0.502295465351041
CASQ2,Calsequestrin-2,NMR metabolomics,X23468.Phenylalanine,37558,0.00432576183795127,0.00449151369632353,-0.00447760500684284,0.0131291286827454,0.335516786891747
CASQ2,Calsequestrin-2,NMR metabolomics,X23469.Tyrosine,37545,-0.0038815597670594,0.00453386807017981,-0.0127679411846118,0.00500482165049303,0.391944069405269
CASQ2,Calsequestrin-2,NMR metabolomics,X23470.Glucose,37538,-0.015682852459778,0.00479074679169754,-0.0250727161715052,-0.00629298874805081,0.00106473051913739
CASQ2,Calsequestrin-2,NMR metabolomics,X23471.Lactate,37537,-0.00331403198513672,0.00450767120883083,-0.0121490675544452,0.00552100358417171,0.462231941019414
CASQ2,Calsequestrin-2,NMR metabolomics,X23472.Pyruvate,37521,-0.00618423899408494,0.00461252463796901,-0.0152247872845042,0.00285630929633432,0.180025178594127
CASQ2,Calsequestrin-2,NMR metabolomics,X23473.Citrate,37560,-0.00870778293038948,0.00457900155761387,-0.0176826259833127,0.000267060122533708,0.0572352694179067
CASQ2,Calsequestrin-2,NMR metabolomics,X23474.3-Hydroxybutyrate,37401,-0.00689773104884799,0.0043403511095247,-0.0154048192235164,0.00160935712582042,0.112037316479782
CASQ2,Calsequestrin-2,NMR metabolomics,X23475.Acetate,37552,-0.00566841236249245,0.00463463846920087,-0.0147523037621262,0.00341547903714126,0.221331363844289
CASQ2,Calsequestrin-2,NMR metabolomics,X23476.Acetoacetate,37561,-0.00811765158653021,0.00447050823758062,-0.0168798477321882,0.000644544559127814,0.0694203657653342
CASQ2,Calsequestrin-2,NMR metabolomics,X23477.Acetone,37561,-0.0029019621451996,0.00448339001767281,-0.0116894065798383,0.00588548228943911,0.517468795071998
CASQ2,Calsequestrin-2,NMR metabolomics,X23478.Creatinine,37173,-0.00423020737026649,0.00539257647400956,-0.0147996572593252,0.00633924251879225,0.432790634505581
CASQ2,Calsequestrin-2,NMR metabolomics,X23479.Albumin,37560,-0.00932458102947713,0.00462803488734829,-0.0183955294086798,-0.000253632650274475,0.0439456188297392
CASQ2,Calsequestrin-2,NMR metabolomics,X23480.Glycoprotein Acetyls,37562,-0.00167394017006133,0.00494459068759122,-0.0113653379177401,0.00801745757761747,0.734961948379673
CASQ2,Calsequestrin-2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,37562,-0.00625369394104007,0.00494295627673963,-0.0159418882434497,0.0034345003613696,0.205831869341304
CASQ2,Calsequestrin-2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,37562,-0.0057401514269548,0.00494568465028779,-0.0154336933415189,0.00395339048760927,0.245810123842274
CASQ2,Calsequestrin-2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,37562,-0.00510843178001217,0.00487007335457399,-0.0146537755549772,0.00443691199495284,0.294223460459806
CASQ2,Calsequestrin-2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,37562,-0.00401832032256786,0.00485846553539914,-0.0135409127719502,0.00550427212681445,0.408209030126621
CASQ2,Calsequestrin-2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,37562,-0.0033970353608646,0.00482052218601975,-0.0128452588454633,0.00605118812373411,0.481007742495226
CASQ2,Calsequestrin-2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,37562,-0.00468362682436022,0.00488561170628961,-0.0142594257686879,0.00489217211996742,0.337749146694518
CASQ2,Calsequestrin-2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,37562,-0.00634057191851283,0.00498164194161209,-0.0161045901240725,0.00342344628704686,0.203116005640406
CASQ2,Calsequestrin-2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,37562,-0.00266051476616869,0.00484568403913668,-0.0121580554828766,0.0068370259505392,0.582981628744129
CASQ2,Calsequestrin-2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,37562,-0.00310913382538887,0.00485456430526599,-0.0126240798637102,0.00640581221293248,0.521887514764754
CASQ2,Calsequestrin-2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,37562,-0.00281802685018819,0.00482168998385943,-0.0122685392185527,0.0066324855181763,0.558929027915084
CASQ2,Calsequestrin-2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,37562,-0.00107796113854617,0.00468550708433,-0.010261555023833,0.00810563274674063,0.818046517302992
CASQ2,Calsequestrin-2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,37562,0.000136445830681357,0.00458892629616045,-0.00885784970979313,0.00913074137115585,0.97627987501855
CASQ2,Calsequestrin-2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,37562,-0.00238232678459906,0.0047848976430554,-0.0117607261649876,0.00699607259578951,0.61857374302154
CASQ2,Calsequestrin-2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,37562,-0.00424958367389708,0.00491091799282293,-0.01387498293983,0.00537581559203588,0.386871399799361
CASQ2,Calsequestrin-2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,37562,-0.0020097455573233,0.00480350721181283,-0.0114246196924764,0.00740512857782984,0.675667910310863
CASQ2,Calsequestrin-2,NMR metabolomics,X23496.Total Lipids in Large VLDL,37562,-0.00186370467290824,0.00479242889282402,-0.0112568653028433,0.00752945595702684,0.69736738578298
CASQ2,Calsequestrin-2,NMR metabolomics,X23497.Phospholipids in Large VLDL,37562,-0.00129020499355421,0.00476891818549387,-0.0106372846371222,0.00805687465001378,0.786745579934103
CASQ2,Calsequestrin-2,NMR metabolomics,X23498.Cholesterol in Large VLDL,37562,-0.000383050358499803,0.0046362892856602,-0.0094701773583938,0.00870407664139419,0.934154935659411
CASQ2,Calsequestrin-2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,37562,0.000692195428432393,0.00452658364480365,-0.00817990851538276,0.00956429937224754,0.878465414389047
CASQ2,Calsequestrin-2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,37562,-0.00145949526874856,0.00475120851372114,-0.010771863955642,0.00785287341814487,0.758708197212467
CASQ2,Calsequestrin-2,NMR metabolomics,X23501.Triglycerides in Large VLDL,37562,-0.00342311086303433,0.00486498625002259,-0.0129584839130786,0.00611226218700994,0.481680765950238
CASQ2,Calsequestrin-2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,37562,-0.00187176471411425,0.00455897874099869,-0.0108073630464717,0.00706383361824318,0.68139701825818
CASQ2,Calsequestrin-2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,37562,-0.00225573279442788,0.00460721156911654,-0.0112858674698963,0.00677440188104054,0.624418714851373
CASQ2,Calsequestrin-2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,37562,-0.00168021318762013,0.00454787587476514,-0.0105940499021598,0.00723362352691955,0.711798229199592
CASQ2,Calsequestrin-2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,37562,-0.00065723075693276,0.00457642262758524,-0.00962701910699983,0.00831255759313431,0.885808803958325
CASQ2,Calsequestrin-2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,37562,0.000127292693042877,0.00465130628557721,-0.00898926762668846,0.00924385301277422,0.97816736756884
CASQ2,Calsequestrin-2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,37562,-0.00139936218474523,0.00453474513657688,-0.0102874626524359,0.00748873828294545,0.757640817659121
CASQ2,Calsequestrin-2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,37562,-0.00263884366802325,0.00477453546781028,-0.0119969331849314,0.00671924584888491,0.580484313123003
CASQ2,Calsequestrin-2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,37562,-0.000657308860463918,0.00459131131799511,-0.00965627904373434,0.0083416613228065,0.8861631418603
CASQ2,Calsequestrin-2,NMR metabolomics,X23510.Total Lipids in Small VLDL,37562,-0.00120524583543943,0.00456566482190802,-0.0101539488863791,0.00774345721550029,0.791799203137622
CASQ2,Calsequestrin-2,NMR metabolomics,X23511.Phospholipids in Small VLDL,37562,-0.000976863379266954,0.00451121267510835,-0.00981884022247932,0.00786511346394542,0.828569287798686
CASQ2,Calsequestrin-2,NMR metabolomics,X23512.Cholesterol in Small VLDL,37562,0.000453563971140563,0.00445721061290548,-0.00828256883015418,0.00918969677243531,0.918949049523424
CASQ2,Calsequestrin-2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,37562,0.00102875239092022,0.00443036202758624,-0.00765475718314881,0.00971226196498924,0.816382388003055
CASQ2,Calsequestrin-2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,37562,-0.000661562928496198,0.00451807571270658,-0.0095169913254011,0.0081938654684087,0.883587499136119
CASQ2,Calsequestrin-2,NMR metabolomics,X23515.Triglycerides in Small VLDL,37562,-0.00275660094949613,0.00472502510609059,-0.0120176501574337,0.00650444825844143,0.559631059380558
CASQ2,Calsequestrin-2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,37562,-0.000493799698490216,0.00461444442579314,-0.00953811077304477,0.00855051137606434,0.9147813084221
CASQ2,Calsequestrin-2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,37562,-0.00056468490820679,0.00461249540019859,-0.00960517589259603,0.00847580607618245,0.902564289524626
CASQ2,Calsequestrin-2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,37562,0.000323638143153026,0.00460287193243764,-0.00869799084442475,0.0093452671307308,0.943946229002187
CASQ2,Calsequestrin-2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,37562,-2.78820560960328e-05,0.00469094780509788,-0.00922213975408788,0.00916637564189581,0.995257652017873
CASQ2,Calsequestrin-2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,37562,-0.000116074415554041,0.00472550447311984,-0.00937806318286893,0.00914591435176084,0.980403593823862
CASQ2,Calsequestrin-2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,37562,0.00029575722868659,0.00462222455681417,-0.00876380290266919,0.00935531736004237,0.948982424265463
CASQ2,Calsequestrin-2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,37562,-0.00283337243850191,0.00469078282765597,-0.0120273067807076,0.00636056190370379,0.545834306443781
CASQ2,Calsequestrin-2,NMR metabolomics,X23523.Concentration of IDL Particles,37562,-0.000646967407168497,0.00463578395625033,-0.00973310396141915,0.00843916914708216,0.889010233858891
CASQ2,Calsequestrin-2,NMR metabolomics,X23524.Total Lipids in IDL,37562,-0.00357395698662078,0.00476309680903498,-0.0129096267323293,0.00576171275908778,0.453061536381461
CASQ2,Calsequestrin-2,NMR metabolomics,X23525.Phospholipids in IDL,37562,-0.00277684469407374,0.00477420193602955,-0.0121342804886917,0.00658059110054418,0.56082231574649
CASQ2,Calsequestrin-2,NMR metabolomics,X23526.Cholesterol in IDL,37562,-0.00346068015904311,0.00476993534588507,-0.0128097534369779,0.00588839311889163,0.468146458608447
CASQ2,Calsequestrin-2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,37562,-0.00349420396704342,0.00476271433480518,-0.0128291240632616,0.00584071612917473,0.463170258360341
CASQ2,Calsequestrin-2,NMR metabolomics,X23528.Free Cholesterol in IDL,37562,-0.00324845926785555,0.00478347258659053,-0.012624065537573,0.00612714700186189,0.497086089086981
CASQ2,Calsequestrin-2,NMR metabolomics,X23529.Triglycerides in IDL,37562,-0.0039531410998435,0.00476208836222627,-0.013286834289807,0.00538055209011998,0.406481745913494
CASQ2,Calsequestrin-2,NMR metabolomics,X23530.Concentration of Large LDL Particles,37562,-0.00211772405191213,0.00459380511094362,-0.0111215820693616,0.00688613396553737,0.644809392264923
CASQ2,Calsequestrin-2,NMR metabolomics,X23531.Total Lipids in Large LDL,37562,-0.00503969304974489,0.00464393616352688,-0.0141418079302576,0.0040624218307678,0.277844121475411
CASQ2,Calsequestrin-2,NMR metabolomics,X23532.Phospholipids in Large LDL,37562,-0.00384698160299748,0.00462092322761654,-0.0129039911291259,0.00521002792313094,0.405134248827674
CASQ2,Calsequestrin-2,NMR metabolomics,X23533.Cholesterol in Large LDL,37562,-0.00512711273926157,0.00465793230340452,-0.0142566600539344,0.00400243457541128,0.271035618085295
CASQ2,Calsequestrin-2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,37562,-0.00544580152804322,0.00463864592680871,-0.0145375475445883,0.00364594448850185,0.240413656794775
CASQ2,Calsequestrin-2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,37562,-0.00405617656553334,0.00470552408983018,-0.0132790037816005,0.00516665065053382,0.388701553611561
CASQ2,Calsequestrin-2,NMR metabolomics,X23536.Triglycerides in Large LDL,37562,-0.00585753750055458,0.00483341791873591,-0.015331036621277,0.00361596162016781,0.225578972560041
CASQ2,Calsequestrin-2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,37562,-0.00194802171725312,0.00455211984352539,-0.0108701766105629,0.00697413317605663,0.668703824497139
CASQ2,Calsequestrin-2,NMR metabolomics,X23538.Total Lipids in Medium LDL,37562,-0.00406034160715354,0.00457588272522229,-0.0130290717485892,0.00490838853428215,0.374914761729742
CASQ2,Calsequestrin-2,NMR metabolomics,X23539.Phospholipids in Medium LDL,37562,-0.00358975731956189,0.00454250573086325,-0.0124930685520539,0.00531355391293008,0.429390654840271
CASQ2,Calsequestrin-2,NMR metabolomics,X23540.Cholesterol in Medium LDL,37562,-0.00380595525686994,0.00457544077556694,-0.0127738191769811,0.00516190866324127,0.405524209533224
CASQ2,Calsequestrin-2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,37562,-0.00389384071832193,0.00459190538225155,-0.012893975267535,0.00510629383089111,0.396464979369178
CASQ2,Calsequestrin-2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,37562,-0.00325580260740454,0.00457792447668261,-0.0122285345817025,0.00571692936689338,0.47697530041834
CASQ2,Calsequestrin-2,NMR metabolomics,X23543.Triglycerides in Medium LDL,37562,-0.00757495303157105,0.0049035531305477,-0.0171859171674445,0.00203601110430244,0.122421539771512
CASQ2,Calsequestrin-2,NMR metabolomics,X23544.Concentration of Small LDL Particles,37562,-0.00330488481509214,0.00454058672842409,-0.0122044348028034,0.00559466517261907,0.466715882031458
CASQ2,Calsequestrin-2,NMR metabolomics,X23545.Total Lipids in Small LDL,37562,-0.00358707407835331,0.00458504269097159,-0.0125737577526576,0.00539960959595099,0.434027405627111
CASQ2,Calsequestrin-2,NMR metabolomics,X23546.Phospholipids in Small LDL,37562,-0.00237168064213055,0.00456426714092691,-0.0113176442383473,0.00657428295408619,0.60333781621051
CASQ2,Calsequestrin-2,NMR metabolomics,X23547.Cholesterol in Small LDL,37562,-0.00340244852773449,0.00457049711826813,-0.01236062287954,0.00555572582407104,0.456625304393888
CASQ2,Calsequestrin-2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,37562,-0.00401953633554433,0.00460130817692696,-0.0130381003623212,0.00499902769123251,0.382371838637179
CASQ2,Calsequestrin-2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,37562,-0.00128366435081516,0.00454595062066665,-0.0101937275673218,0.00762639886569148,0.77766017959897
CASQ2,Calsequestrin-2,NMR metabolomics,X23550.Triglycerides in Small LDL,37562,-0.00703454949680614,0.00493950726274648,-0.0167159837317892,0.00264688473817696,0.15442977213255
CASQ2,Calsequestrin-2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,37562,-0.00604253274938158,0.00531134234559267,-0.0164527637467432,0.00436769824798005,0.25528083399509
CASQ2,Calsequestrin-2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,37562,-0.00409350548987106,0.00534015274929451,-0.0145602048784883,0.00637319389874618,0.443361645934682
CASQ2,Calsequestrin-2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,37562,-0.003574457944688,0.00533988191166843,-0.0140406264915581,0.00689171060218212,0.503259186808274
CASQ2,Calsequestrin-2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,37562,-0.00379430931662316,0.00530710614689768,-0.0141962373645426,0.0066076187312963,0.474653395082804
CASQ2,Calsequestrin-2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,37562,-0.00511358092564707,0.00539452502581312,-0.0156868499762408,0.00545968812494665,0.343187393763759
CASQ2,Calsequestrin-2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,37562,0.000440974287011926,0.00493543235102947,-0.00923247312100583,0.0101144216950297,0.928806185218344
CASQ2,Calsequestrin-2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,37562,-0.00708986254995638,0.00477882663588022,-0.0164563627562816,0.00227663765636885,0.137939367078002
CASQ2,Calsequestrin-2,NMR metabolomics,X23558.Concentration of Large HDL Particles,37562,-0.0129405840774137,0.00562233898507554,-0.0239603684881618,-0.00192079966666568,0.0213712475675921
CASQ2,Calsequestrin-2,NMR metabolomics,X23559.Total Lipids in Large HDL,37562,-0.0126493016708862,0.00559135379292311,-0.0236083551050155,-0.00169024823675694,0.0236953708857814
CASQ2,Calsequestrin-2,NMR metabolomics,X23560.Phospholipids in Large HDL,37562,-0.0127418852785764,0.00551623719173281,-0.0235537101743727,-0.00193006038278008,0.0209098599614783
CASQ2,Calsequestrin-2,NMR metabolomics,X23561.Cholesterol in Large HDL,37562,-0.0116821830276241,0.00559530243456461,-0.0226489757993707,-0.000715390255877423,0.0368301243090811
CASQ2,Calsequestrin-2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,37562,-0.0116376986086154,0.00557832837160719,-0.0225712222169655,-0.000704175000265306,0.0369767068886656
CASQ2,Calsequestrin-2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,37562,-0.0112962358234503,0.0055876699934628,-0.0222480690106374,-0.000344402636263199,0.0432342271799342
CASQ2,Calsequestrin-2,NMR metabolomics,X23564.Triglycerides in Large HDL,37562,-0.00711119284545708,0.00470582578163345,-0.0163346113774586,0.00211222568654449,0.130775194512763
CASQ2,Calsequestrin-2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,37562,-0.0157742468562554,0.00500328754017098,-0.0255806904349905,-0.00596780327752027,0.00162090241050021
CASQ2,Calsequestrin-2,NMR metabolomics,X23566.Total Lipids in Medium HDL,37562,-0.0153751998626582,0.00495689122160396,-0.0250907066570019,-0.00565969306831441,0.00192767487009493
CASQ2,Calsequestrin-2,NMR metabolomics,X23567.Phospholipids in Medium HDL,37562,-0.0149908649658809,0.00492298650750511,-0.0246399185205909,-0.00534181141117092,0.00233083631820924
CASQ2,Calsequestrin-2,NMR metabolomics,X23568.Cholesterol in Medium HDL,37562,-0.0152753991624126,0.00502608061743585,-0.0251265171725869,-0.00542428115223831,0.002376535638121
CASQ2,Calsequestrin-2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,37562,-0.0150331850148525,0.00500104603385529,-0.0248352352412089,-0.00523113478849616,0.00265202984486606
CASQ2,Calsequestrin-2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,37562,-0.0157521795777516,0.00509003417034115,-0.0257286465516203,-0.00577571260388297,0.00197420239620311
CASQ2,Calsequestrin-2,NMR metabolomics,X23571.Triglycerides in Medium HDL,37562,-0.00387222693119831,0.00454772694599462,-0.0127857717453478,0.00504131788295115,0.39452706426525
CASQ2,Calsequestrin-2,NMR metabolomics,X23572.Concentration of Small HDL Particles,37562,-0.0104957750800511,0.00449823283781998,-0.0193123114421783,-0.00167923871792399,0.0196468814843661
CASQ2,Calsequestrin-2,NMR metabolomics,X23573.Total Lipids in Small HDL,37562,-0.0109522073964273,0.00454134673246731,-0.0198532469920633,-0.00205116780079142,0.0158935140337747
CASQ2,Calsequestrin-2,NMR metabolomics,X23574.Phospholipids in Small HDL,37562,-0.0112540990086752,0.00458603777046677,-0.0202427330387901,-0.00226546497856031,0.0141409334715471
CASQ2,Calsequestrin-2,NMR metabolomics,X23575.Cholesterol in Small HDL,37562,-0.0106407082976038,0.00450805543190152,-0.0194764969441308,-0.00180491965107683,0.0182709538633605
CASQ2,Calsequestrin-2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,37562,-0.00942882712790946,0.00445955455987463,-0.0181695540652637,-0.00068810019055518,0.0345086527926461
CASQ2,Calsequestrin-2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,37562,-0.0129046442225869,0.00467736540213654,-0.0220722804107745,-0.00373700803439924,0.00580668051489567
CASQ2,Calsequestrin-2,NMR metabolomics,X23578.Triglycerides in Small HDL,37562,-0.00175477060878705,0.00470537154951748,-0.0109772988458413,0.0074677576282672,0.709207142343804
CASQ2,Calsequestrin-2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36847,0.00459166437424064,0.00429925839326871,-0.00383488207656604,0.0130182108250473,0.285535392937462
CASQ2,Calsequestrin-2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36847,0.00797113192437421,0.00449653950350178,-0.000842085502489291,0.0167843493512377,0.0762986968568859
CASQ2,Calsequestrin-2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36847,0.00662360940401016,0.00438512317868122,-0.00197123202620504,0.0152184508342254,0.13094830902214
CASQ2,Calsequestrin-2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36847,0.0046079257494464,0.00458392621260853,-0.00437656962726632,0.0135924211261591,0.314803047006397
CASQ2,Calsequestrin-2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36847,-0.00840126768876387,0.00435380578211227,-0.0169347270217039,0.000132191644176185,0.0536745414882466
CASQ2,Calsequestrin-2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,37362,0.00172183438513408,0.00422245582607526,-0.00655417903397344,0.00999784780424159,0.683441725626771
CASQ2,Calsequestrin-2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,37362,0.00626913347372237,0.00481834194705993,-0.00317481674251508,0.0157130836899598,0.193248246069558
CASQ2,Calsequestrin-2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,37362,0.00644064944432339,0.00483111862159766,-0.00302834305400803,0.0159096419426548,0.182503143253497
CASQ2,Calsequestrin-2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,37362,0.00478917003220413,0.00455041471390362,-0.00412964280704697,0.0137079828714552,0.292604163803846
CASQ2,Calsequestrin-2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,37362,-0.00713316033934109,0.00462053252436118,-0.016189404087089,0.00192308340840682,0.122662233843407
CASQ2,Calsequestrin-2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,37557,0.0012244819324324,0.00451213320419484,-0.00761929914778949,0.0100682630126543,0.786106598294124
CASQ2,Calsequestrin-2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,37557,0.00770427292413115,0.00443045257109313,-0.000979414115211378,0.0163879599634737,0.0820695251872927
CASQ2,Calsequestrin-2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,37557,0.00888442161930368,0.00465276693280774,-0.000235001568999488,0.0180038448076069,0.0562204549156561
CASQ2,Calsequestrin-2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,37557,0.00480200050105199,0.0042603519603713,-0.00354828934127575,0.0131522903433797,0.259705181722939
CASQ2,Calsequestrin-2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,37557,-0.00746425961616203,0.00418038145745974,-0.0156578072727831,0.000729288040459067,0.0741960605744908
CASQ2,Calsequestrin-2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,37562,0.00239294488421029,0.00468911849420942,-0.00679772736444018,0.0115836171328608,0.609836791124212
CASQ2,Calsequestrin-2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,37562,0.00185505696588745,0.00490248836405573,-0.00775382022766178,0.0114639341594367,0.705146356938146
CASQ2,Calsequestrin-2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,37562,0.00169519612627066,0.00494251950713304,-0.0079921421077101,0.0113825343602514,0.731617363774942
CASQ2,Calsequestrin-2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,37562,0.00184372699579636,0.00478802968295944,-0.00754081118280415,0.0112282651743969,0.700191738036603
CASQ2,Calsequestrin-2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,37562,-0.00206048000558375,0.00486644084867513,-0.011598704068987,0.00747774405781951,0.672006050936154
CASQ2,Calsequestrin-2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,37562,0.00117457399263862,0.00477342649634485,-0.00818134194019729,0.0105304899254745,0.805635638303697
CASQ2,Calsequestrin-2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,37562,0.00543318150655359,0.00465181628361185,-0.00368437840932563,0.0145507414224328,0.242840137193722
CASQ2,Calsequestrin-2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,37562,0.0079306469687632,0.00452041980412166,-0.000929375847315247,0.0167906697848417,0.079384500972983
CASQ2,Calsequestrin-2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,37562,0.000857281229860467,0.00478752229588161,-0.00852626247006748,0.0102408249297884,0.857888848646471
CASQ2,Calsequestrin-2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,37562,-0.00426059899026971,0.00469465714575866,-0.0134621269959567,0.00494092901541725,0.364136879599084
CASQ2,Calsequestrin-2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,37562,0.00777838897496498,0.00478133892705264,-0.00159303532205819,0.0171498132719882,0.103798868642478
CASQ2,Calsequestrin-2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,37562,0.00185326384203952,0.00495999197151787,-0.00786832042213551,0.0115748481062145,0.708676345504022
CASQ2,Calsequestrin-2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,37562,0.00125652316238796,0.00499586302021541,-0.00853536835723425,0.0110484146820102,0.801421661117811
CASQ2,Calsequestrin-2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,37562,0.00510619986177552,0.00482738628933597,-0.00435547726532299,0.014567876988874,0.290185898639855
CASQ2,Calsequestrin-2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,37562,-0.00392169337956053,0.00494695592183699,-0.013617726986361,0.00577434022723997,0.427938536534275
CASQ2,Calsequestrin-2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,37562,0.00540695543258357,0.00448807968946787,-0.00338968075877345,0.0142035916239406,0.228326614624317
CASQ2,Calsequestrin-2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,37562,-0.000801982121542565,0.00474608712686938,-0.0101043128902065,0.00850034864712141,0.865816915709053
CASQ2,Calsequestrin-2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,37562,-0.00150399511896725,0.00474836883051784,-0.0108107980267822,0.00780280778884771,0.751446453219899
CASQ2,Calsequestrin-2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,37562,0.000284925539226678,0.00483376807758549,-0.00918925989284089,0.00975911097129424,0.952996965537641
CASQ2,Calsequestrin-2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,37562,-0.000628401700191646,0.00488903097390661,-0.0102109024090486,0.00895409900866532,0.897729175265043
CASQ2,Calsequestrin-2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,37562,0.00946247934247228,0.00447564210664232,0.000690220813453334,0.0182347378714912,0.0345155519026468
CASQ2,Calsequestrin-2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,37562,-0.00532575543386592,0.00491549740447961,-0.014960130346646,0.00430861947891412,0.278623263747867
CASQ2,Calsequestrin-2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,37562,-0.00772626099028449,0.00452475858213216,-0.0165947878112635,0.00114226583069454,0.0877431605512622
CASQ2,Calsequestrin-2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,37562,0.00225080635222765,0.00489338010134972,-0.0073402186464178,0.0118418313508731,0.645545630367705
CASQ2,Calsequestrin-2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,37562,-0.000409988573166107,0.00487279919259311,-0.00996067499064859,0.00914069784431638,0.932947834488158
CASQ2,Calsequestrin-2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,37562,0.0030302979376696,0.00441773941224905,-0.00562847131033854,0.0116890671856777,0.492763964789087
CASQ2,Calsequestrin-2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,37562,0.00109717051393011,0.00453701548768339,-0.00779537984192934,0.00998972086978955,0.808918397116587
CASQ2,Calsequestrin-2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,37562,-0.00125470379072451,0.00461328256600205,-0.0102967376200885,0.00778733003863951,0.785644480800077
CASQ2,Calsequestrin-2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,37562,0.000285571051077486,0.00499615146481921,-0.00950688581996816,0.0100780279221231,0.954420042129792
CASQ2,Calsequestrin-2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,37562,-0.00333705825171394,0.00470219319131366,-0.0125533569066887,0.00587924040326084,0.477914455462682
CASQ2,Calsequestrin-2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,37562,0.00510883383246113,0.00450930580138553,-0.00372940553825451,0.0139470732031768,0.257254496356444
CASQ2,Calsequestrin-2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,37562,-0.00157305726666496,0.00455788257119264,-0.0105065071062025,0.00736039257287262,0.730002960263664
CASQ2,Calsequestrin-2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,37562,-0.00404671044623513,0.00455421691842698,-0.012972975606352,0.00487955471388175,0.374254073627108
CASQ2,Calsequestrin-2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,37562,0.00266045028129483,0.00487655852492164,-0.00689760442755159,0.0122185049901412,0.585378411457299
CASQ2,Calsequestrin-2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,37562,-0.00399629030021386,0.00481269480288187,-0.0134291721138623,0.00543659151343461,0.40634792338037
CASQ2,Calsequestrin-2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,37560,-0.000303768854599315,0.00519363169547229,-0.010483286977725,0.00987574926852637,0.953360241177555
CASQ2,Calsequestrin-2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,37560,0.00280902501994099,0.00518713272190305,-0.00735775511498899,0.012975805154871,0.588146609380647
CASQ2,Calsequestrin-2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,37560,-0.0056396639865091,0.00519672338443433,-0.0158252418200004,0.00454591384698219,0.277837724742249
CASQ2,Calsequestrin-2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,37560,0.0117353819042291,0.00552412479015547,0.000908097315524417,0.0225626664929338,0.0336564145267438
CASQ2,Calsequestrin-2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,37560,-0.0016355525946599,0.00517394189906537,-0.011776478716828,0.00850537352750822,0.751921435698662
CASQ2,Calsequestrin-2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,37562,0.00233785216494376,0.00537394218859907,-0.00819507452471042,0.0128707788545979,0.663544288393052
CASQ2,Calsequestrin-2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,37562,-0.00395133957549413,0.00535049665069117,-0.0144383130108488,0.00653563385986057,0.460224136974614
CASQ2,Calsequestrin-2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,37562,-0.00478470749075941,0.00539753091485205,-0.0153638680838694,0.0057944531023506,0.375384738837783
CASQ2,Calsequestrin-2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,37562,-0.000148110021031491,0.00519904667995546,-0.0103382415137442,0.0100420214716812,0.977273436930668
CASQ2,Calsequestrin-2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,37562,0.00377425236191109,0.00520554870113577,-0.00642862309231502,0.0139771278161372,0.46843791804943
CASQ2,Calsequestrin-2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,37562,0.00951482827909268,0.00507057102032787,-0.000423490920749949,0.0194531474789353,0.0606115082343132
CASQ2,Calsequestrin-2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,37562,-0.00669912900413395,0.00495306931628456,-0.0164071448640517,0.00300888685578379,0.176232114114752
CASQ2,Calsequestrin-2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,37562,-0.00473898546561444,0.00491639003834421,-0.0143751099407691,0.00489713900954022,0.335105979189504
CASQ2,Calsequestrin-2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,37562,-0.0120570645927811,0.00533895095255122,-0.0225214084597814,-0.00159272072578065,0.0239420268566664
CASQ2,Calsequestrin-2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,37562,0.00463488005948137,0.00482376722212192,-0.00481970369587759,0.0140894638148403,0.336649138067451
CASQ2,Calsequestrin-2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,37562,-0.00274006695858705,0.00468579757056555,-0.0119242301968955,0.00644409627972142,0.558719171000505
CASQ2,Calsequestrin-2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,37562,-0.00113291166807371,0.00470476834643143,-0.0103542576270793,0.00808843429093189,0.809713326679798
CASQ2,Calsequestrin-2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,37562,0.000337367991273118,0.00472171194313403,-0.00891718741726958,0.00959192339981581,0.943040424923498
CASQ2,Calsequestrin-2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,37562,-0.00452904591185456,0.00483516609663334,-0.0140059714612559,0.00494787963754678,0.348935915128934
CASQ2,Calsequestrin-2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,37562,0.00388873866960863,0.00482537677666463,-0.00556899981265404,0.0133464771518713,0.420319009186342
CASQ2,Calsequestrin-2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,47544,0.0110544799129962,0.00383373681771616,0.00354035575027257,0.0185686040757199,0.0039367847756546
CASQ2,Calsequestrin-2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,47544,0.00971603603941264,0.00375826160631221,0.0023498432910407,0.0170822287877846,0.00973698526157006
CASQ2,Calsequestrin-2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,45877,0.000773152260101969,0.00358742408952878,-0.00625819895537444,0.00780450347557838,0.829366010427641
CASQ2,Calsequestrin-2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,45877,0.0101501254465456,0.00391942559321051,0.00246805128385303,0.0178321996092382,0.00961253752322684
CASQ2,Calsequestrin-2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,45877,0.00933201638204692,0.00383208548202694,0.00182112883727412,0.0168429039268197,0.0148903540542293
CASQ2,Calsequestrin-2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,45877,-0.00425316256115592,0.0035205132488146,-0.0111533685288325,0.00264704340652069,0.227018801749559
CASQ2,Calsequestrin-2,Working and living environment,X24009.Traffic intensity on the nearest road,47544,0.0553502227247063,0.0515029946537916,-0.0455956467967253,0.156296092246138,0.282520690079668
CASQ2,Calsequestrin-2,Working and living environment,X24010.Inverse distance to the nearest road,47544,0.00580050371367006,0.00336267511923175,-0.000790339520024163,0.0123913469473643,0.0845467947261679
CASQ2,Calsequestrin-2,Working and living environment,X24011.Traffic intensity on the nearest major road,47544,-0.00383603598422973,0.00336374850152138,-0.0104289830472116,0.00275691107875217,0.254129391956279
CASQ2,Calsequestrin-2,Working and living environment,X24012.Inverse distance to the nearest major road,47544,0.00465924775939933,0.0034308976227932,-0.00206531158127535,0.011383807100074,0.1744687410109
CASQ2,Calsequestrin-2,Working and living environment,X24013.Total traffic load on major roads,47544,0.0294238824623004,0.0368701849207779,-0.0428416799824243,0.101689444907025,0.424855483577677
CASQ2,Calsequestrin-2,Working and living environment,X24015.Sum of road length of major roads within 100m,47544,0.0192861319727486,0.0359537033495009,-0.0511831265922732,0.0897553905377703,0.59167643103451
CASQ2,Calsequestrin-2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,47544,0.0101251446375937,0.00382235786863464,0.0026333232150698,0.0176169660601176,0.00808028546211444
CASQ2,Calsequestrin-2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,47544,0.0102702253242627,0.00381520276146532,0.00279242791179067,0.0177480227367347,0.00710929216882283
CASQ2,Calsequestrin-2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,47544,0.00950506648731869,0.0037811085269281,0.00209409377453961,0.0169160392000978,0.0119495228487413
CASQ2,Calsequestrin-2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,47489,0.0055333593705047,0.00370533247691618,-0.00172909228425102,0.0127958110252604,0.135359210187066
CASQ2,Calsequestrin-2,Working and living environment,X24020.Average daytime sound level of noise pollution,47544,0.00314043173040624,0.00339082086943682,-0.00350557717368993,0.0097864406345024,0.354374189808996
CASQ2,Calsequestrin-2,Working and living environment,X24021.Average evening sound level of noise pollution,47544,0.00315988278328579,0.00339091762972686,-0.00348631577097886,0.00980608133755045,0.351415228096137
CASQ2,Calsequestrin-2,Working and living environment,X24022.Average night-time sound level of noise pollution,47544,0.00314358412906824,0.00339080052507904,-0.00350238490008668,0.00978955315822316,0.353888445211984
CASQ2,Calsequestrin-2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,47544,0.0031626975897411,0.00339080454706241,-0.00348327932250123,0.00980867450198343,0.350970290966556
CASQ2,Calsequestrin-2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,47544,0.00315944377839342,0.00339090416269018,-0.00348672838047934,0.00980561593726617,0.351480233430961
CASQ2,Calsequestrin-2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44900,-0.0124929704047552,0.00392477102345614,-0.0201855216107292,-0.00480041919878115,0.00145921318504447
CASQ2,Calsequestrin-2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44900,0.00835535885077372,0.00358112962380659,0.0013363447881128,0.0153743729134346,0.0196492403504642
CASQ2,Calsequestrin-2,Working and living environment,"X24502.Water percentage, buffer 1000m",44900,-0.00511409542280572,0.00350861378399116,-0.0119909784394284,0.00176278759381695,0.144970905275564
CASQ2,Calsequestrin-2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44900,-0.00800880227318877,0.00370145340752603,-0.0152636509519398,-0.000753953594437745,0.0304995977402324
CASQ2,Calsequestrin-2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44900,0.00470432871723679,0.00361574952677837,-0.00238254035524881,0.0117911977897224,0.193250530059284
CASQ2,Calsequestrin-2,Working and living environment,"X24505.Water percentage, buffer 300m",44900,0.000128047686067766,0.00354065309164184,-0.00681163237355024,0.00706772774568577,0.971151154125648
CASQ2,Calsequestrin-2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",47686,-0.0101903829368745,0.00373446511510531,-0.0175099345624809,-0.0028708313112681,0.00636246955011882
CASQ2,Calsequestrin-2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",47686,-0.00739501705598336,0.00352802044870051,-0.0143099371354364,-0.000480096976530348,0.0360857850357065
CASQ2,Calsequestrin-2,Working and living environment,X24508.Distance (Euclidean) to coast,47686,0.00293535765761489,0.00335618484942537,-0.00364276464725882,0.00951347996248861,0.381794402570886
CASQ2,Calsequestrin-2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,33920,0.0430605527879342,0.0389417565531349,-0.0332652900562103,0.119386395632079,0.268854997775348
CASQ2,Calsequestrin-2,Health and medical history,X2704.Years since last cervical smear test,42265,-0.00148439206683969,0.02877589876037,-0.0578851536371649,0.0549163695034856,0.958860300995269
CASQ2,Calsequestrin-2,Health and medical history,X2714.Age when periods started (menarche),47116,0.0121844827923123,0.0243446495380246,-0.0355310303022159,0.0598999958868404,0.616728329859414
CASQ2,Calsequestrin-2,Health and medical history,X2734.Number of live births,47824,0.017672345982539,0.0235114659730714,-0.028410127324681,0.0637548192897591,0.452270350690319
CASQ2,Calsequestrin-2,Health and medical history,X2744.Birth weight of first child,43044,0.0213768820851828,0.0258255571526861,-0.0292412099340819,0.0719949741044475,0.407827613719909
CASQ2,Calsequestrin-2,Health and medical history,X2754.Age at first live birth,40263,0.00484539344412514,0.00433237597574954,-0.00364606346834396,0.0133368503565942,0.26340686491324
CASQ2,Calsequestrin-2,Health and medical history,X2764.Age at last live birth,40215,0.00186047601042677,0.00417774662222956,-0.00632790736914317,0.0100488593899967,0.656087387739051
CASQ2,Calsequestrin-2,Health and medical history,X2794.Age started oral contraceptive pill,42342,0.00212845506149733,0.00471351195753403,-0.00711002837526936,0.011366938498264,0.651588163344085
CASQ2,Calsequestrin-2,Health and medical history,X2804.Age when last used oral contraceptive pill,40672,0.0035727510301951,0.00410448181242843,-0.00447203332216463,0.0116175353825548,0.384066770537082
CASQ2,Calsequestrin-2,Lifestyle factors,X2867.Age started smoking in former smokers,29227,-0.00887282487911014,0.00731774372230106,-0.0232156025748202,0.00546995281659995,0.225377859744029
CASQ2,Calsequestrin-2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",33612,0.0593562205373802,0.0429275099295415,-0.024781698924521,0.143494139999281,0.166788066780439
CASQ2,Calsequestrin-2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,33606,-0.023091569403389,0.0480046519135656,-0.117180687153978,0.0709975483471995,0.630508280098608
CASQ2,Calsequestrin-2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,33635,0.0304117335790302,0.0513718576181092,-0.0702771073524639,0.131100574510524,0.553870459662003
CASQ2,Calsequestrin-2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",33594,0.0466007314723768,0.0487045726670955,-0.0488602309551304,0.142061693899884,0.338691483425473
CASQ2,Calsequestrin-2,Mental health,X28739.Difficulty with standing for long periods,33650,-0.0227742219625493,0.0438726255876829,-0.108764568114408,0.0632161241893091,0.603704423191694
CASQ2,Calsequestrin-2,Mental health,X28740.Difficulty with taking care of household responsibilities,33674,0.0080940659420234,0.047301166498745,-0.0846162203955169,0.100804352279564,0.8641349885627
CASQ2,Calsequestrin-2,Mental health,X28741.Difficulty learning a new task,33577,0.0442117221106679,0.0520894026337946,-0.0578835070515695,0.146306951272905,0.396033697403888
CASQ2,Calsequestrin-2,Mental health,X28742.Difficulty with joining in community activities,33344,0.0381056805759725,0.0547708051124565,-0.0692450974444423,0.145456458596387,0.486616256069256
CASQ2,Calsequestrin-2,Mental health,X28743.Difficulty with being emotionally affected by health problems,33610,0.02074392665902,0.0459717066722993,-0.0693606184186866,0.110848471736727,0.651832699096623
CASQ2,Calsequestrin-2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,33664,0.0326780745963006,0.067686161459527,-0.0999868018643723,0.165342951056973,0.629257663528711
CASQ2,Calsequestrin-2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29206,-0.0243445778335899,0.0576715663840652,-0.137380847946358,0.0886916922791779,0.672953280053705
CASQ2,Calsequestrin-2,Lifestyle factors,X2897.Age stopped smoking,29234,-0.0188063691220489,0.00750894367604093,-0.0335238987270891,-0.00408883951700869,0.0122944629169519
CASQ2,Calsequestrin-2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,32730,0.00145156492248708,0.0110928128931871,-0.0202903483481597,0.0231934781931339,0.8958921311091
CASQ2,Calsequestrin-2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,32730,-0.00192403664431555,0.0118204124180907,-0.0250920449837733,0.0212439716951422,0.870701630069045
CASQ2,Calsequestrin-2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,32730,0.0366041546118714,0.0398981514073111,-0.0415962221464583,0.114804531370201,0.358938919301917
CASQ2,Calsequestrin-2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,32730,0.0258846848537299,0.0425583190481903,-0.057529620480723,0.109298990188183,0.543060376886056
CASQ2,Calsequestrin-2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,32730,-0.0425444925685864,0.043576605544502,-0.12795463943581,0.0428656542986375,0.328936930551575
CASQ2,Calsequestrin-2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,32730,-0.0162317948860425,0.0355366112332174,-0.0858835529031486,0.0534199631310637,0.647853676261699
CASQ2,Calsequestrin-2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,32730,0.0134824360241538,0.0168007626780881,-0.0194470588248989,0.0464119308732065,0.422292884418445
CASQ2,Calsequestrin-2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,32730,0.0252490962894541,0.0291375194208312,-0.031860441775375,0.0823586343542832,0.386214133005075
CASQ2,Calsequestrin-2,Mental health,X29002.Recent lack of interest or pleasure in doing things,32676,-0.00831366248209733,0.0543227547010839,-0.114786261696222,0.0981589367320271,0.878368917634892
CASQ2,Calsequestrin-2,Mental health,X29003.Recent feelings of depression,32663,0.0557114998910485,0.0502635473305465,-0.0428050528768226,0.15422805265892,0.26772686752134
CASQ2,Calsequestrin-2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",32682,-0.0195770583558909,0.0421138095084793,-0.10212012499251,0.0629660082807285,0.642043459189998
CASQ2,Calsequestrin-2,Mental health,X29005.Recent feelings of tiredness or low energy,32690,0.0192119699966825,0.0429013181823668,-0.0648746136407564,0.103298553634121,0.654296540549747
CASQ2,Calsequestrin-2,Mental health,X29006.Recent poor appetite or overeating,32694,0.0480158391566661,0.0548470688439347,-0.059484415777446,0.155516094090778,0.381354892364177
CASQ2,Calsequestrin-2,Mental health,X29007.Recent feelings of inadequacy,32651,0.0291329692810665,0.0546543959353269,-0.0779896467521743,0.136255585314307,0.594020467767806
CASQ2,Calsequestrin-2,Mental health,X29008.Recent trouble concentrating on things,32692,0.0382821863911692,0.0555323971738917,-0.0705613120696585,0.147125684851997,0.490611938220957
CASQ2,Calsequestrin-2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,32681,0.0469322384761911,0.0984899200511239,-0.146108004824012,0.239972481776394,0.633717906449354
CASQ2,Calsequestrin-2,Mental health,X29010.Recent thoughts of suicide or self-harm,32623,0.0825590742429725,0.105476053372393,-0.124173990366917,0.289292138852862,0.433809467521666
CASQ2,Calsequestrin-2,Mental health,X29038#0.Substances taken for depression_None of options listed,31791,0.0274754019241513,0.0222598171907329,-0.0161538397696851,0.0711046436179877,0.217128823576747
CASQ2,Calsequestrin-2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),31791,-0.0108852384871591,0.043754227471506,-0.0966435243313109,0.0748730473569928,0.803536831649457
CASQ2,Calsequestrin-2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),31791,-0.000406083668465269,0.020722841717612,-0.0410228534349848,0.0402106860980543,0.984366231263829
CASQ2,Calsequestrin-2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),31791,-0.00193989109747137,0.0608550917264701,-0.121215870881353,0.11733608868641,0.974570832697802
CASQ2,Calsequestrin-2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),31791,-0.00926962729523355,0.0380974869639599,-0.083940701744595,0.0654014471541279,0.807769461192368
CASQ2,Calsequestrin-2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),31791,-0.0384590912995628,0.0396087767688145,-0.116092293766439,0.0391741111673137,0.331593239132375
CASQ2,Calsequestrin-2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),31791,0.0412536239264216,0.0480206503274829,-0.0528668507154449,0.135374098568288,0.390323937502544
CASQ2,Calsequestrin-2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),31791,-0.0627347601613968,0.0514391765081361,-0.163555546117343,0.0380860257945499,0.222659126918463
CASQ2,Calsequestrin-2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),31791,-0.00970693994647305,0.0392932050285004,-0.0867216218023339,0.0673077419093878,0.804885229877655
CASQ2,Calsequestrin-2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,31791,0.0383922125507389,0.0222736064529992,-0.0052640560971395,0.0820484811986174,0.0848106421474767
CASQ2,Calsequestrin-2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,31791,0.0521577698249617,0.0335014969173338,-0.0135051641330125,0.117820703782936,0.119542386183198
CASQ2,Calsequestrin-2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,31791,-0.0035487599428369,0.0530679905792475,-0.107562021478162,0.100464501592488,0.946685466314753
CASQ2,Calsequestrin-2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,31791,-0.0504057198592827,0.0701586767190541,-0.187916726228629,0.0871052865100632,0.472500817962775
CASQ2,Calsequestrin-2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,31791,0.0145589627053913,0.0465093830683989,-0.0765994281086705,0.105717353519453,0.754264632854534
CASQ2,Calsequestrin-2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,31791,0.0833158163910729,0.0785490083204627,-0.0706402399170341,0.23727187269918,0.288867627688637
CASQ2,Calsequestrin-2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,31791,-0.0389360500034792,0.0728596187362876,-0.181740902726603,0.103868802719644,0.593082243249979
CASQ2,Calsequestrin-2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,31791,-0.00229302112033604,0.0390563529167003,-0.0788434728370686,0.0742574305963965,0.953184230947568
CASQ2,Calsequestrin-2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,31791,0.0124199204109007,0.038170603731781,-0.0623944629033901,0.0872343037251914,0.744903373219438
CASQ2,Calsequestrin-2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,31791,-0.0166970236115876,0.0528373035490325,-0.120258138567691,0.086864091344516,0.752005235728418
CASQ2,Calsequestrin-2,Mental health,X29058.Recent feelings or nervousness or anxiety,32557,0.0451936655817487,0.0471802192292223,-0.0472795641075269,0.137666895271024,0.338144612862319
CASQ2,Calsequestrin-2,Mental health,X29059.Recent inability to stop or control worrying,32568,0.0159976581444848,0.0488023885157861,-0.0796550233464559,0.111650339635425,0.743067700862156
CASQ2,Calsequestrin-2,Mental health,X29060.Recent worrying too much about different things,32561,0.0436031551521573,0.0456513906789648,-0.0458735705786137,0.133079880882928,0.33953886148807
CASQ2,Calsequestrin-2,Mental health,X29061.Recent trouble relaxing,32568,0.011718509812125,0.0480545064305553,-0.0824683227917634,0.105905342416013,0.807346415968254
CASQ2,Calsequestrin-2,Mental health,X29062.Recent restlessness,32576,0.0382672408152624,0.0689336164783694,-0.0968426474823417,0.173377129112866,0.578819818791587
CASQ2,Calsequestrin-2,Mental health,X29063.Recent easy annoyance or irritability,32544,-0.0448238677882698,0.0516859019051948,-0.146128235522452,0.056480499945912,0.385838511323288
CASQ2,Calsequestrin-2,Mental health,X29064.Recent feelings of foreboding,32533,-0.0121879953012941,0.0549502445746514,-0.119890474667611,0.0955144840650227,0.824474745482373
CASQ2,Calsequestrin-2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,31791,-0.0206323298709458,0.0222195587873698,-0.0641826650941907,0.022918005352299,0.353144516154758
CASQ2,Calsequestrin-2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,31791,-0.0596730663639039,0.0381518216249758,-0.134450636748857,0.0151045040210487,0.117838419170894
CASQ2,Calsequestrin-2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',31791,0.0168970565414992,0.048745722858071,-0.0786445602603201,0.112438673343318,0.728874208282529
CASQ2,Calsequestrin-2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,31791,-0.0277764100949496,0.0539088732345581,-0.133437801634683,0.0778849814447843,0.606395625844047
CASQ2,Calsequestrin-2,Mental health,X29065#2.Symptoms of panic attack_Sweating,31791,-0.0535699797131499,0.0361106013021252,-0.124346758265315,0.0172067988390155,0.13798527387143
CASQ2,Calsequestrin-2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,31791,0.0114088748291664,0.0361431803453175,-0.059431758647656,0.0822495083059888,0.752271277727147
CASQ2,Calsequestrin-2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,31791,-0.0429812231983271,0.0375834564764362,-0.116644797892142,0.0306823514954878,0.252818225705223
CASQ2,Calsequestrin-2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,31791,-0.0553999305979389,0.0329920364072816,-0.120064321956211,0.00926446076033302,0.0931573932402935
CASQ2,Calsequestrin-2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,31791,-0.0115412762358788,0.0448877002303865,-0.0995211686874364,0.0764386162156788,0.797097632918683
CASQ2,Calsequestrin-2,Mental health,X29076.Felt loved as a child,32542,-0.0143781500683987,0.0445322443934554,-0.101661349079571,0.0729050489427738,0.74680163067148
CASQ2,Calsequestrin-2,Mental health,X29077.Physically abused by family as a child,32559,-0.0331787751568621,0.0640027703591264,-0.15862420506075,0.0922666547470257,0.604196212339545
CASQ2,Calsequestrin-2,Mental health,X29078.Felt hated by family member as a child,32538,-0.0255367027208631,0.0593064668337186,-0.141777377714952,0.0907039722732254,0.666778838390189
CASQ2,Calsequestrin-2,Mental health,X29079.Sexually molested as a child,32452,0.00920922327336783,0.0732867459767125,-0.134432798840989,0.152851245387724,0.900004108585489
CASQ2,Calsequestrin-2,Mental health,X29080.Someone to take to doctor when needed as a child,32522,-0.0401218919555782,0.0618913723877569,-0.161428981835582,0.0811851979244254,0.516833257063129
CASQ2,Calsequestrin-2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,32535,-0.00429393573963983,0.0790314941623908,-0.159195664297926,0.150607792818646,0.956672032087739
CASQ2,Calsequestrin-2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,32472,0.0221070940606726,0.0584619820286669,-0.0924783907155146,0.13669257883686,0.705333044151531
CASQ2,Calsequestrin-2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,32538,0.0314908455379779,0.0646132934698534,-0.0951512096629347,0.15813290073889,0.626006460722555
CASQ2,Calsequestrin-2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,32500,-0.0937826878076711,0.0869969040038025,-0.264296619655124,0.0767312440397817,0.281065939602661
CASQ2,Calsequestrin-2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,32508,-0.00846037577205879,0.0820392785148782,-0.16925736166122,0.152336610117102,0.917865603624973
CASQ2,Calsequestrin-2,Mental health,X29086.Experienced a violent or sexual assault,32536,0.0430205355597367,0.0740881069800137,-0.10219215412109,0.188233225240563,0.561480942587905
CASQ2,Calsequestrin-2,Mental health,X29087.Experienced a life-threatening injury or illness,32549,0.029298274652549,0.0538002913832805,-0.0761502964586808,0.134746845763779,0.586061094825085
CASQ2,Calsequestrin-2,Mental health,X29088.Experienced a marital separation or divorce,32550,-0.0114661152403132,0.0483549244345655,-0.106241767132062,0.0833095366514351,0.812566558545619
CASQ2,Calsequestrin-2,Mental health,X29089.Experienced the death of a spouse or partner,32558,-0.0622760879962503,0.0634003235156463,-0.186540722086917,0.0619885460944165,0.325997317635087
CASQ2,Calsequestrin-2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,32546,0.0520185295391348,0.0593631594374664,-0.0643332629582993,0.168370322036569,0.380905855574863
CASQ2,Calsequestrin-2,Lifestyle factors,X29091.Frequency of drinking alcohol,32554,-0.018070258576896,0.0403247094921821,-0.0971066891815729,0.0609661720277809,0.654079480641216
CASQ2,Calsequestrin-2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,31497,-0.0129164531876009,0.050166103469974,-0.11124201598875,0.0854091096135482,0.796820624385552
CASQ2,Calsequestrin-2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,31512,-0.021914057981038,0.0507281025691767,-0.121341139016624,0.0775130230545482,0.665761521809183
CASQ2,Calsequestrin-2,Mental health,X29104.Ever used cannabis,32549,0.104598410859405,0.0582604806275415,-0.00959213117057665,0.218788952889386,0.072633994546758
CASQ2,Calsequestrin-2,Mental health,X29108.Ever thought that life not worth living,32508,0.0345164798082416,0.0481719945669331,-0.0599006295429472,0.12893358915943,0.473687479222168
CASQ2,Calsequestrin-2,Mental health,X29109.Ever contemplated self-harm,32533,0.0574982425157004,0.0625636210268477,-0.0651264546969211,0.180122939728322,0.358103988463789
CASQ2,Calsequestrin-2,Mental health,X29111.Ever self-harmed,32547,0.120037790144257,0.0929602536628869,-0.0621643070350016,0.302239887323515,0.196643203684729
CASQ2,Calsequestrin-2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,32539,-0.0167108414515884,0.0686083396000119,-0.151183187067612,0.117761504164435,0.807571080663821
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,32377,0.00289096840170055,0.0471365126739873,-0.0894965964393145,0.0952785332427156,0.951096491466986
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,32377,-0.00938089701755241,0.0372715742512471,-0.0824331825499967,0.0636713885148918,0.801286912655619
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,32377,-0.0308291852865136,0.0376742970957353,-0.104670807594155,0.0430124370211276,0.413205843061597
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,32377,-0.0163059633351214,0.0481911503468248,-0.110760618014898,0.0781486913446552,0.735100787758754
CASQ2,Calsequestrin-2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,32534,-0.040930220433854,0.0455445362509156,-0.130197511485649,0.0483370706179405,0.368846907181221
CASQ2,Calsequestrin-2,Health and medical history,X29153.Pain or discomfort today,32546,-0.0028219164850915,0.0435482419955164,-0.0881764707963036,0.0825326378261206,0.948335017761192
CASQ2,Calsequestrin-2,Mental health,X29154.Anxiety or depression today,32546,-0.0489387717781166,0.0532136003752453,-0.153237428513598,0.0553598849573642,0.357774420141291
CASQ2,Calsequestrin-2,Mental health,X29166.Frequency of confiding in someone close,32341,0.0659444158351667,0.0422573132246411,-0.0168799180851298,0.148768749755463,0.118671405244651
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,32519,-0.00692344443705723,0.0118666820637642,-0.0301821412820351,0.0163352524079207,0.559616427743294
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,32519,0.00366049472020899,0.011676193209749,-0.019224843970899,0.026545833411317,0.753908395886264
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,32519,-0.0142110254592413,0.0171469271302962,-0.0478190026346218,0.0193969517161392,0.407253586339471
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,32519,-0.0159355657787233,0.014835203512294,-0.0450125646628195,0.0131414331053729,0.282777559960847
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,32519,-0.0243259170616249,0.0218272170182069,-0.0671072624173104,0.0184554282940605,0.265108088505478
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,32519,0.00729791183568994,0.0116126909114295,-0.015462962350712,0.0300587860220918,0.529731707281169
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,32517,0.0167896661104493,0.0128682727788284,-0.00843214853605438,0.042011480756953,0.19202085022941
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,32517,-0.0146290589891953,0.0180249063898339,-0.0499578755132697,0.0206997575348792,0.417043711399314
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,32517,-0.0347057642509533,0.0379548147511699,-0.109097201163246,0.0396856726613398,0.36053567598402
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,32517,-0.0152227109882224,0.0248435326014765,-0.0639160348871163,0.0334706129106716,0.54006328823667
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,32517,-0.0107786868616544,0.034761874008823,-0.0789119599189475,0.0573545861956386,0.756514148985892
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,32517,-0.0157145505204362,0.0182436024349059,-0.0514720112928518,0.0200429102519794,0.389058130357566
CASQ2,Calsequestrin-2,Mental health,X29171.Frequency of feeling 'in tune' with people,32428,0.0712883623022691,0.0535040017392942,-0.0335794811067475,0.176156205711286,0.182769120537059
CASQ2,Calsequestrin-2,Mental health,X29172.Freuency of feeling that lacks companionship,32496,-0.0708512901015448,0.0471749658327178,-0.163314223133672,0.021611642930582,0.133166525085437
CASQ2,Calsequestrin-2,Mental health,X29173.Frequency of feeling left out,32445,-0.0336718906780402,0.0490909185718931,-0.129890091078951,0.0625463097228703,0.49279054749845
CASQ2,Calsequestrin-2,Mental health,X29174.Frequency of feeling isolated from others,32472,-0.0777605055413176,0.0518000545576218,-0.179288612474256,0.0237676013916211,0.133351879536855
CASQ2,Calsequestrin-2,Mental health,X29175.Tendency to bounce back quickly after hard times,32535,0.0554978541697889,0.0431207495742255,-0.0290188149956932,0.140014523335271,0.198119440425714
CASQ2,Calsequestrin-2,Mental health,X29176.Ability to make it through stressful events,32535,-0.0666024290502834,0.0404947638393732,-0.145972166175455,0.012767308074888,0.100067072445298
CASQ2,Calsequestrin-2,Mental health,X29177.Quick recovery from stressful events,32535,0.0485753189282216,0.0425541497207022,-0.0348308145243546,0.131981452380798,0.253698114951302
CASQ2,Calsequestrin-2,Mental health,X29178.Hard to snap back when something bad happens,32535,-0.078595519000592,0.0412587618866311,-0.159462692298389,0.00227165429720502,0.0568231725039702
CASQ2,Calsequestrin-2,Mental health,X29179.Comes through difficult times with little trouble,32535,0.0435462082115652,0.0423936827386063,-0.039545409956103,0.126637826379233,0.304363517594609
CASQ2,Calsequestrin-2,Mental health,X29180.Tendency to take a long time to get over setbacks,32535,-0.140141435402223,0.0416839788323974,-0.221842033913722,-0.0584408368907241,0.000777399519037307
CASQ2,Calsequestrin-2,Mental health,X29181.General happiness,32487,-0.00874401690394297,0.0433033542836493,-0.0936185912998955,0.0761305574920096,0.839980704929787
CASQ2,Calsequestrin-2,Mental health,X29182.Belief that own life is meaningful,32399,0.0528088444286925,0.0428176185758557,-0.0311136879799847,0.13673137683737,0.217484014673926
CASQ2,Calsequestrin-2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28840,-0.0435987615146904,0.0573882886050512,-0.156079807180591,0.06888228415121,0.447465596441243
CASQ2,Calsequestrin-2,Health and medical history,X2946.Father's age,29679,-0.00887926143706889,0.0107505534847004,-0.0299503462670817,0.0121918233929439,0.408878500238152
CASQ2,Calsequestrin-2,Health and medical history,X2966.Age high blood pressure diagnosed,29407,0.011090150523857,0.00779237842120231,-0.0041829111816995,0.0263632122294136,0.154739746490477
CASQ2,Calsequestrin-2,Blood and urine assays,X30000.White blood cell (leukocyte) count,47060,-0.00317334349096433,0.00353545109962302,-0.0101028276462255,0.00375614066429679,0.369420075469296
CASQ2,Calsequestrin-2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47060,-0.0037840582543898,0.00416262098091056,-0.0119427953769745,0.0043746788681949,0.363329917883234
CASQ2,Calsequestrin-2,Blood and urine assays,X30020.Haemoglobin concentration,47060,-0.00349753841180212,0.00452835119745397,-0.0123731067588119,0.00537802993520767,0.439906555310258
CASQ2,Calsequestrin-2,Blood and urine assays,X30030.Haematocrit percentage,47060,-0.00324907846931329,0.00439623808567925,-0.0118657051172446,0.00536754817861803,0.459878962474054
CASQ2,Calsequestrin-2,Blood and urine assays,X30040.Mean corpuscular volume,47060,0.000155716083714112,0.00347660734014714,-0.00665843430297429,0.00696986647040251,0.96427535724974
CASQ2,Calsequestrin-2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47059,5.74839877928129e-05,0.00348699457745128,-0.0067770253840117,0.00689199335959732,0.986847412373312
CASQ2,Calsequestrin-2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47059,-0.000568014164116944,0.00341533030212509,-0.00726206155628213,0.00612603322804824,0.867912045999105
CASQ2,Calsequestrin-2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47060,0.00151913979303812,0.00329584743925409,-0.0049407211878999,0.00797900077397614,0.64485656296819
CASQ2,Calsequestrin-2,Blood and urine assays,X30080.Platelet count,47060,-0.0026835252036297,0.00348934943012967,-0.00952265008668384,0.00415559967942445,0.441864683672704
CASQ2,Calsequestrin-2,Blood and urine assays,X30090.Platelet crit,47060,-0.00099329217652019,0.00357938288426878,-0.008008882629687,0.00602229827664662,0.781395863381107
CASQ2,Calsequestrin-2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47060,0.00306110546006203,0.00337422082126838,-0.003552367349624,0.00967457826974806,0.364308780809317
CASQ2,Calsequestrin-2,Blood and urine assays,X30110.Platelet distribution width,47060,0.0048213810079915,0.00337898675106763,-0.00180143302410105,0.011444195040084,0.153630651957259
CASQ2,Calsequestrin-2,Blood and urine assays,X30120.Lymphocyte count,47028,-0.00116899901350721,0.0035125452245727,-0.0080535876536697,0.00571558962665527,0.739283198508684
CASQ2,Calsequestrin-2,Blood and urine assays,X30130.Monocyte count,47028,0.0018788746279467,0.00356731936147512,-0.00511307132054454,0.00887082057643795,0.598413433932505
CASQ2,Calsequestrin-2,Blood and urine assays,X30140.Neutrophill count,47028,-0.00407008200098047,0.00351732895592497,-0.0109640467545934,0.00282388275263247,0.247222767225187
CASQ2,Calsequestrin-2,Blood and urine assays,X30150.Eosinophill count,47028,-0.00197298819998671,0.00346056411577892,-0.00875569386691339,0.00480971746693997,0.568591913954332
CASQ2,Calsequestrin-2,Blood and urine assays,X30160.Basophill count,47028,0.0075998049424858,0.0267695096097247,-0.0448684338925745,0.0600680437775461,0.776491304472166
CASQ2,Calsequestrin-2,Blood and urine assays,X30170.Nucleated red blood cell count,47028,0.0504162558675238,0.111812195403733,-0.168735647123793,0.26956815885884,0.652065071380365
CASQ2,Calsequestrin-2,Blood and urine assays,X30180.Lymphocyte percentage,47028,0.0019576564088032,0.00347305300173385,-0.00484952747459514,0.00876484029220154,0.572984214352796
CASQ2,Calsequestrin-2,Blood and urine assays,X30190.Monocyte percentage,47028,0.0053861742046641,0.00352234471798258,-0.00151762144258175,0.0122899698519099,0.126242625350928
CASQ2,Calsequestrin-2,Blood and urine assays,X30200.Neutrophill percentage,47028,-0.0033891083788456,0.00344195154897391,-0.0101353334148345,0.00335711665714326,0.324807888115934
CASQ2,Calsequestrin-2,Blood and urine assays,X30210.Eosinophill percentage,47028,0.00141113488531128,0.00341866878798556,-0.00528945593914042,0.00811172570976298,0.67977670186872
CASQ2,Calsequestrin-2,Blood and urine assays,X30220.Basophill percentage,47028,0.00265373072468017,0.00327678887073966,-0.00376877546196956,0.0090762369113299,0.418030847620386
CASQ2,Calsequestrin-2,Blood and urine assays,X30230.Nucleated red blood cell percentage,47028,0.050286512228547,0.111780723085621,-0.168803705019271,0.269376729476365,0.652810316814545
CASQ2,Calsequestrin-2,Blood and urine assays,X30240.Reticulocyte percentage,46636,-0.00166876462949098,0.00360101935047786,-0.00872676255642759,0.00538923329744562,0.643071824047074
CASQ2,Calsequestrin-2,Blood and urine assays,X30250.Reticulocyte count,46636,-0.00260729094047575,0.0037206432680871,-0.00989975174592646,0.00468516986497495,0.483457979644609
CASQ2,Calsequestrin-2,Blood and urine assays,X30260.Mean reticulocyte volume,46636,0.00284318805469471,0.0034358391155279,-0.00389105661173997,0.00957743272112939,0.407957480810399
CASQ2,Calsequestrin-2,Blood and urine assays,X30270.Mean sphered cell volume,46636,0.00672910020216506,0.00347732097866907,-8.64489160263158e-05,0.0135446493203564,0.0529859082629868
CASQ2,Calsequestrin-2,Blood and urine assays,X30280.Immature reticulocyte fraction,46636,0.00411154527462684,0.00364145000949363,-0.00302569674398068,0.0112487872932344,0.258869705903331
CASQ2,Calsequestrin-2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,46636,0.000798412958686464,0.00370184460825807,-0.00645720247349936,0.00805402839087229,0.829239361526544
CASQ2,Calsequestrin-2,Blood and urine assays,X30300.High light scatter reticulocyte count,46636,-0.000128331429509843,0.0037944936044076,-0.00756553889414874,0.00730887603512905,0.973020643672941
CASQ2,Calsequestrin-2,Blood and urine assays,X30500.Microalbumin in urine,30945,-0.0068325492026303,0.0066270367677992,-0.0198215412675167,0.00615644286225613,0.302573964455749
CASQ2,Calsequestrin-2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47112,-0.00160964159987754,0.00361180554111696,-0.00868878046046679,0.00546949726071171,0.655846251676337
CASQ2,Calsequestrin-2,Blood and urine assays,X30520.Potassium in urine,47071,0.00012978746988643,0.00335290937358545,-0.00644191490234104,0.0067014898421139,0.969122810556178
CASQ2,Calsequestrin-2,Blood and urine assays,X30530.Sodium in urine,47045,0.00141260943928634,0.00354097423857057,-0.00552770006831198,0.00835291894688466,0.689946767013005
CASQ2,Calsequestrin-2,Blood and urine assays,X30600.Albumin,44720,-0.00277698022891218,0.00376615055855319,-0.0101586353236764,0.00460467486585207,0.460916597633074
CASQ2,Calsequestrin-2,Blood and urine assays,X30610.Alkaline phosphatase,46711,0.00528411808814725,0.0035398973381749,-0.00165408069467555,0.01222231687097,0.135521522347236
CASQ2,Calsequestrin-2,Blood and urine assays,X30620.Alanine aminotransferase,46720,0.00166450762099871,0.00369339662628728,-0.00557454976652436,0.00890356500852178,0.6522309045521
CASQ2,Calsequestrin-2,Blood and urine assays,X30630.Apolipoprotein A,44523,-0.0100851763128541,0.00414217124644563,-0.0182038319558876,-0.00196652066982067,0.0149104873550717
CASQ2,Calsequestrin-2,Blood and urine assays,X30640.Apolipoprotein B,46618,-0.00105864496737596,0.00351950353438286,-0.00795687189476636,0.00583958196001444,0.763574530528184
CASQ2,Calsequestrin-2,Blood and urine assays,X30650.Aspartate aminotransferase,46655,0.00690638766845485,0.00356725260068284,-8.54274288835215e-05,0.0138982027657932,0.0528739699592701
CASQ2,Calsequestrin-2,Blood and urine assays,X30660.Direct bilirubin,41750,-0.0103507012339281,0.00397707616541224,-0.0181457705181361,-0.00255563194972015,0.00926012638972836
CASQ2,Calsequestrin-2,Blood and urine assays,X30670.Urea,46709,0.000645409689514638,0.00370150159124315,-0.00660953342932193,0.00790035280835121,0.861580764297234
CASQ2,Calsequestrin-2,Blood and urine assays,X30680.Calcium,44723,0.00132340355395995,0.00361641856528868,-0.00576477683400586,0.00841158394192576,0.714411325674025
CASQ2,Calsequestrin-2,Blood and urine assays,X30690.Cholesterol,46720,-0.00272137898328557,0.00362645814485816,-0.00982923694720756,0.00438647898063642,0.453007682244053
CASQ2,Calsequestrin-2,Blood and urine assays,X30700.Creatinine,46715,-0.00254486607654762,0.00410570051528301,-0.0105920390865023,0.00550230693340707,0.535371291846057
CASQ2,Calsequestrin-2,Blood and urine assays,X30710.C-reactive protein,46660,-0.000845334421760435,0.00385371511591666,-0.0083986160489571,0.00670794720543623,0.826374982783672
CASQ2,Calsequestrin-2,Blood and urine assays,X30720.Cystatin C,46720,0.00678813303651887,0.00399955339702021,-0.00105099162164074,0.0146272576946785,0.0896685287228705
CASQ2,Calsequestrin-2,Blood and urine assays,X30730.Gamma glutamyltransferase,46716,-0.0029958673492142,0.00363579075065229,-0.0101220172204927,0.00413028252206428,0.409952171317214
CASQ2,Calsequestrin-2,Blood and urine assays,X30740.Glucose,44700,-0.00551082806738284,0.00390545876497407,-0.013165527246732,0.00214387111196633,0.158242934792485
CASQ2,Calsequestrin-2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),46627,0.000274934457053604,0.00393303912889835,-0.00743382223558715,0.00798369114969436,0.944270843442088
CASQ2,Calsequestrin-2,Blood and urine assays,X30760.HDL cholesterol,44711,-0.00991318002807859,0.00434697172210074,-0.018433244603396,-0.00139311545276114,0.0225896020103981
CASQ2,Calsequestrin-2,Blood and urine assays,X30770.IGF-1,46592,0.00144299000646481,0.00354476731142072,-0.00550475392391981,0.00839073393684943,0.683956041324766
CASQ2,Calsequestrin-2,Blood and urine assays,X30780.LDL direct,46670,-0.00144949866472949,0.00353165095692499,-0.00837153454030247,0.00547253721084348,0.68149384407771
CASQ2,Calsequestrin-2,Blood and urine assays,X30790.Lipoprotein A,42265,0.00390134845538215,0.00385360489322806,-0.00365171713534485,0.0114544140461091,0.311365691550436
CASQ2,Calsequestrin-2,Blood and urine assays,X30810.Phosphate,44681,0.0060239471809625,0.00389590401185851,-0.00161202468228018,0.0136599190442052,0.122065694874656
CASQ2,Calsequestrin-2,Blood and urine assays,X30830.SHBG,44496,0.00306116056703724,0.00410201521666877,-0.00497878925763355,0.011101110391708,0.45552049222116
CASQ2,Calsequestrin-2,Blood and urine assays,X30840.Total bilirubin,46641,-0.00715765397245556,0.00356098394912306,-0.0141371825127368,-0.000178125432174352,0.0444410035606652
CASQ2,Calsequestrin-2,Blood and urine assays,X30850.Testosterone,42891,-0.00154706797803239,0.00628312099003268,-0.0138619851184964,0.0107678491624317,0.805510002448334
CASQ2,Calsequestrin-2,Blood and urine assays,X30860.Total protein,44719,0.0030320696261511,0.00368788724827253,-0.00419618938046306,0.0102603286327653,0.410989920212281
CASQ2,Calsequestrin-2,Blood and urine assays,X30870.Triglycerides,46714,-0.000574228565229034,0.00391891349256647,-0.00825529901065931,0.00710684188020125,0.88350631546526
CASQ2,Calsequestrin-2,Blood and urine assays,X30880.Urate,46691,-0.00113681530025267,0.00434419392761005,-0.00965143539836838,0.00737780479786303,0.793565857545368
CASQ2,Calsequestrin-2,Blood and urine assays,X30890.Vitamin D,45428,-0.00274661031983949,0.00385963854613424,-0.0103115018702626,0.00481828123058361,0.476705731603731
CASQ2,Calsequestrin-2,Physical measures,X3137.Number of measurements made,45785,-0.0331528510564198,0.0295080274845739,-0.0909885849261846,0.0246828828133451,0.26122946969679
CASQ2,Calsequestrin-2,Physical measures,X3143.Ankle spacing width,37667,0.00955276763733698,0.00594939675094448,-0.00210804999451421,0.0212135852691882,0.108370338862667
CASQ2,Calsequestrin-2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",37666,0.00300040703433976,0.00482797232247236,-0.00646241871770607,0.0124632327863856,0.534305633702581
CASQ2,Calsequestrin-2,Physical measures,X3146.Speed of sound through heel,37667,-0.000731324860714334,0.00465361995340571,-0.00985241996938952,0.00838977024796085,0.875127596667923
CASQ2,Calsequestrin-2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",37667,0.000562510594565997,0.00471345421311535,-0.00867585966314009,0.00980088085227208,0.90500663726484
CASQ2,Calsequestrin-2,Physical measures,X3148.Heel bone mineral density (BMD),37665,0.000772635330536962,0.00470190310519571,-0.00844309475564662,0.00998836541672055,0.869478635452649
CASQ2,Calsequestrin-2,Health and medical history,X3526.Mother's age at death,38377,-0.00280086201564664,0.00443341564475852,-0.0114903566793733,0.00588863264808007,0.52755300272033
CASQ2,Calsequestrin-2,Health and medical history,X3581.Age at menopause (last menstrual period),37841,0.00551981227433024,0.00453993343327789,-0.00337845725489443,0.0144180818035549,0.224069025363212
CASQ2,Calsequestrin-2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29259,-0.00129509616849322,0.00767517923656299,-0.0163384474721567,0.0137482551351702,0.866009645128929
CASQ2,Calsequestrin-2,Physical measures,X4100.Ankle spacing width (left),32048,0.00329755430757743,0.00820520419636865,-0.0127846459173051,0.01937975453246,0.687779447343397
CASQ2,Calsequestrin-2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32048,-0.00169411578981056,0.00667605306482554,-0.0147791797968686,0.0113909482172475,0.799687780176089
CASQ2,Calsequestrin-2,Physical measures,X4103.Speed of sound through heel (left),32048,-0.00265453003890444,0.00651312183447792,-0.0154202488344812,0.0101111887566723,0.68360347466592
CASQ2,Calsequestrin-2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32048,-0.00234915622875065,0.00656854630227088,-0.0152235069812016,0.0105251945237003,0.720624803731894
CASQ2,Calsequestrin-2,Physical measures,X4105.Heel bone mineral density (BMD) (left),32046,-0.00252734462076193,0.00655163565341207,-0.0153685505014496,0.0103138612599257,0.699686849777589
CASQ2,Calsequestrin-2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32048,-0.0023473592781774,0.00656811035505386,-0.015220855574083,0.0105261370177282,0.720811805755451
CASQ2,Calsequestrin-2,Physical measures,X4119.Ankle spacing width (right),32048,-0.00274426955157932,0.00810419724913038,-0.0186284961598749,0.0131399570567162,0.734902930338837
CASQ2,Calsequestrin-2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32048,0.000360823072574407,0.00667545402941601,-0.012723066825081,0.0134447129702298,0.956894985374821
CASQ2,Calsequestrin-2,Physical measures,X4122.Speed of sound through heel (right),32048,0.000472003342020767,0.00652565427614458,-0.0123182790392226,0.0132622857232642,0.942340857399543
CASQ2,Calsequestrin-2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32048,0.000577177510896912,0.0065712743389507,-0.0123025201934465,0.0134568752152403,0.930011388954706
CASQ2,Calsequestrin-2,Physical measures,X4124.Heel bone mineral density (BMD) (right),32045,0.000902387978136648,0.00656162493199295,-0.0119583968885695,0.0137631728448428,0.890619418444706
CASQ2,Calsequestrin-2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32048,0.000575169530172575,0.00657127588572979,-0.0123045312058578,0.013454870266203,0.930254270973798
CASQ2,Calsequestrin-2,Physical measures,X4194.Pulse rate,32284,0.0013416915975589,0.00638480158884339,-0.0111725195165741,0.0138559027116919,0.833565169816611
CASQ2,Calsequestrin-2,Physical measures,X4195.Pulse wave reflection index,32284,-0.000786784956097169,0.00634353951915469,-0.0132201224136404,0.011646552501446,0.90129523524907
CASQ2,Calsequestrin-2,Physical measures,X4196.Pulse wave peak to peak time,32282,-0.00418107824419995,0.00579436096060402,-0.0155380257269838,0.00717586923858393,0.470576061459121
CASQ2,Calsequestrin-2,Physical measures,X4198.Position of the pulse wave peak,32284,0.00162380065282424,0.00559918905306563,-0.00935060989118439,0.0125982111968329,0.771819019851823
CASQ2,Calsequestrin-2,Physical measures,X4199.Position of pulse wave notch,32284,-0.00135963982904934,0.00624803892556099,-0.0136057961231489,0.0108865164650502,0.827738152494159
CASQ2,Calsequestrin-2,Physical measures,X4200.Position of the shoulder on the pulse waveform,32284,0.00262877359399058,0.00558963308931262,-0.00832690726106215,0.0135844544490433,0.638157735246121
CASQ2,Calsequestrin-2,Physical measures,X4269.Number of triplets attempted (left),32196,-0.0755814079908242,0.119636024695582,-0.310068016394164,0.158905200412516,0.527561561279524
CASQ2,Calsequestrin-2,Physical measures,X4270.Volume level set by participant (left),32122,0.0341494296205044,0.0397939064605783,-0.0438466270422291,0.112145486283238,0.390832460127769
CASQ2,Calsequestrin-2,Physical measures,X4276.Number of triplets attempted (right),32194,-0.0586003933408938,0.118952788626164,-0.291747859048175,0.174547072366388,0.622283994057002
CASQ2,Calsequestrin-2,Physical measures,X4277.Volume level set by participant (right),32104,-0.0395429734278255,0.040250406639449,-0.118433770441145,0.0393478235854945,0.325921982918768
CASQ2,Calsequestrin-2,Cognitive function,X4288.Time to answer,32341,-0.0154542856192084,0.00722344488103342,-0.0296122375860339,-0.00129633365238292,0.0324288702187171
CASQ2,Calsequestrin-2,Cognitive function,X4290.Duration screen displayed,32341,-0.00534965670523812,0.00631987411283992,-0.0177366099664044,0.00703729655592812,0.397309849219901
CASQ2,Calsequestrin-2,Physical measures,X46.Hand grip strength (left),47761,0.00228476639015222,0.00510439989036035,-0.00771985739495406,0.0122893901752585,0.654440830593097
CASQ2,Calsequestrin-2,Physical measures,X47.Hand grip strength (right),47762,0.00308300353647651,0.00509895851708014,-0.00691095515700057,0.0130769622299536,0.545428114735761
CASQ2,Calsequestrin-2,Physical measures,X48.Waist circumference,47835,0.00299094094264671,0.00679663383586188,-0.0103304613756426,0.016312343260936,0.659896199910539
CASQ2,Calsequestrin-2,Health and medical history,X4803.Tinnitus,32191,-0.041566839325102,0.0496341797601774,-0.13884983165505,0.0557161530048457,0.402357668606414
CASQ2,Calsequestrin-2,Working and living environment,X4825.Noisy workplace,32321,0.00972587403608574,0.0693415987207669,-0.126183659456617,0.145635407528789,0.888457914169853
CASQ2,Calsequestrin-2,Working and living environment,X4836.Loud music exposure frequency,32270,-0.0744449632492758,0.0860752688422768,-0.243152490180138,0.0942625636815868,0.387130021214629
CASQ2,Calsequestrin-2,Physical measures,X49.Hip circumference,47833,0.00648774262850841,0.00575878310398932,-0.00479947225531067,0.0177749575123275,0.259930724155421
CASQ2,Calsequestrin-2,Physical measures,X50.Standing height,47830,0.0044445070902247,0.00471914551473407,-0.00480501811865408,0.0136940322991035,0.34630305764999
CASQ2,Calsequestrin-2,Health and medical history,X5057.Number of older siblings,31409,-0.0233728799498558,0.0422575898982898,-0.106197756150504,0.0594519962507921,0.580209357775714
CASQ2,Calsequestrin-2,Physical measures,X51.Seated height,47728,0.00195485875033139,0.00472752061063497,-0.00731108164651315,0.0112207991471759,0.679239642002157
CASQ2,Calsequestrin-2,Eye measures,X5181.Ever had eye surgery,29792,-0.0275692590089304,0.0986752256105632,-0.220972701205634,0.165834183187773,0.779953353687356
CASQ2,Calsequestrin-2,Eye measures,X5186.Duration visual-acuity screen displayed (right),29778,0.0078607600513075,0.00740545485225924,-0.00665393145912061,0.0223754515617356,0.288518853471475
CASQ2,Calsequestrin-2,Eye measures,X5188.Duration visual-acuity screen displayed (left),29779,0.00210355719752703,0.00737902990314382,-0.0123593414126348,0.0165664558076889,0.775599815777852
CASQ2,Calsequestrin-2,Eye measures,X5190.Duration at which refractometer first shown (right),29714,0.00246664494492738,0.0074131860695253,-0.0120631997513422,0.016996489641197,0.73934570063212
CASQ2,Calsequestrin-2,Eye measures,X5193.Duration at which refractometer first shown (left),29714,0.00582367590921193,0.00745415504866247,-0.00878646798616651,0.0204338198045904,0.434681367437256
CASQ2,Calsequestrin-2,Eye measures,"X5199.logMAR, initial (right)",29760,-0.0902623729263032,0.0501851294784288,-0.188625226704024,0.0081004808514173,0.0721406746799851
CASQ2,Calsequestrin-2,Eye measures,X5200.Final number of letters displayed (right),29760,0.148954550380793,0.410726621633329,-0.656069628020532,0.953978728782118,0.716872539192855
CASQ2,Calsequestrin-2,Eye measures,"X5201.logMAR, final (right)",29717,-0.00851168150919429,0.00772255060354789,-0.0236478806921482,0.00662451767375957,0.270431515186477
CASQ2,Calsequestrin-2,Eye measures,X5202.Number of rounds to result (right),29760,-0.0593863943057331,0.0477359410720362,-0.152948838806924,0.0341760501954578,0.213532379038226
CASQ2,Calsequestrin-2,Eye measures,"X5206.logMAR, initial (left)",29759,-0.0356907395188515,0.0493008542381353,-0.132320413825597,0.0609389347878937,0.469135992706526
CASQ2,Calsequestrin-2,Eye measures,X5207.Final number of letters displayed (left),29759,0.675444587883535,0.444786493540125,-0.196336939455109,1.54722611522218,0.128927433566066
CASQ2,Calsequestrin-2,Eye measures,"X5208.logMAR, final (left)",29704,-0.00827949756843248,0.00764591656128475,-0.0232654940285506,0.00670649889168563,0.278917937373294
CASQ2,Calsequestrin-2,Eye measures,X5209.Number of rounds to result (left),29757,-0.00877588091098736,0.0467959895845205,-0.100496020496648,0.0829442586746729,0.851248455018962
CASQ2,Calsequestrin-2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29511,-0.00531970171932789,0.00760107054308671,-0.0202177999837778,0.00957839654512206,0.484045564608783
CASQ2,Calsequestrin-2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29511,-0.0104553030312044,0.00762822822964797,-0.0254066303613144,0.00449602429890564,0.170558306369675
CASQ2,Calsequestrin-2,Eye measures,X5256.Corneal hysteresis (right),29511,-0.00550706952560904,0.00756965996238678,-0.0203436030518871,0.00932946400066904,0.466941902291537
CASQ2,Calsequestrin-2,Eye measures,X5257.Corneal resistance factor (right),29511,-0.00855799375481953,0.00755854315836166,-0.0233727383452084,0.00625675083556933,0.257592277432609
CASQ2,Calsequestrin-2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29505,0.0047338830458689,0.0076460642336672,-0.0102524028521188,0.0197201689438566,0.535860761045321
CASQ2,Calsequestrin-2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29505,-0.00457453705934871,0.00756778495865001,-0.0194073955783027,0.0102583214596053,0.54555500369538
CASQ2,Calsequestrin-2,Eye measures,X5264.Corneal hysteresis (left),29505,-0.0147427838682801,0.00774303808996773,-0.0299191385246168,0.000433570788056645,0.0569662698010372
CASQ2,Calsequestrin-2,Eye measures,X5265.Corneal resistance factor (left),29505,-0.0125621268644611,0.00763230547951825,-0.0275214456043168,0.00239719187539471,0.0998434304812253
CASQ2,Calsequestrin-2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29102,-0.599968958480662,0.309781534271981,-1.20714076565375,0.00720284869242149,0.0528365984697243
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",47759,-0.0489089982379738,0.0196446616330819,-0.0874125350388143,-0.0104054614371333,0.0127925901804846
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",47759,0.00722453049522046,0.0204760977765257,-0.03290862114677,0.0473576821372109,0.724220952660412
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",47759,-0.0436007013073866,0.0524807983819302,-0.14646306613597,0.0592616635211966,0.406098857953327
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",47759,-0.0121037757372105,0.00864621929399581,-0.0290503655534423,0.00484281407902123,0.161558885157745
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",47759,0.00688819981832848,0.00790299326244393,-0.00860166697606162,0.0223780666127186,0.383438999753249
CASQ2,Calsequestrin-2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",35201,0.00338845062592575,0.0095613620109895,-0.0153518189156137,0.0221287201674652,0.723053615382251
CASQ2,Calsequestrin-2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",35201,-0.00947522695517282,0.0235428642451889,-0.0556192408757431,0.0366687869653975,0.687348341548889
CASQ2,Calsequestrin-2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",35201,0.00428842553601425,0.0186669313567131,-0.0322987599231434,0.0408756109951719,0.818302980741386
CASQ2,Calsequestrin-2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",35201,0.0265370278554011,0.0115003798293135,0.0039962833899466,0.0490777723208556,0.021046342849188
CASQ2,Calsequestrin-2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,47825,-0.0278437572309515,0.0160575298503043,-0.0593165157375478,0.00362900127564488,0.0829312635379789
CASQ2,Calsequestrin-2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,47825,-0.0278437572309515,0.0160575298503043,-0.0593165157375478,0.00362900127564488,0.0829312635379789
CASQ2,Calsequestrin-2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),47825,-0.000633177691115037,0.0130138169675455,-0.0261402589475042,0.0248739035652741,0.96119524014463
CASQ2,Calsequestrin-2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',47825,0.0267167996690683,0.0201289892847218,-0.0127360193289864,0.066169618667123,0.18442912753743
CASQ2,Calsequestrin-2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),47825,-0.0377395353695998,0.05128074233605,-0.138249790348258,0.0627707196090583,0.461774766137441
CASQ2,Calsequestrin-2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),47825,-0.0677485542830217,0.035115740599813,-0.136575405858655,0.0010782972926119,0.0537065827919425
CASQ2,Calsequestrin-2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,47825,-0.0134066669724088,0.0546992453205847,-0.120617187800755,0.0938038538559373,0.806382825777807
CASQ2,Calsequestrin-2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,47759,0.000580646673051623,0.0104743707840351,-0.0199491200636571,0.0211104134097604,0.955792393316752
CASQ2,Calsequestrin-2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,47759,0.00838598998524979,0.0174765718606292,-0.0258680908615834,0.042640070832083,0.631344378978501
CASQ2,Calsequestrin-2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,47759,0.0137513421653898,0.00932195867887652,-0.00451969684520818,0.0320223811759878,0.14018414772218
CASQ2,Calsequestrin-2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,47759,-0.00631257313707268,0.0172619733993563,-0.040146040999811,0.0275208947256657,0.714597908251083
CASQ2,Calsequestrin-2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,47759,0.00164244287821536,0.0167329430482982,-0.031154125496449,0.0344390112528798,0.921809069143344
CASQ2,Calsequestrin-2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,47759,0.00602176383539444,0.00937729982806489,-0.0123577438276127,0.0244012714984016,0.520773057545072
CASQ2,Calsequestrin-2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,30643,-0.0237445666787774,0.0343325966238967,-0.091036456061615,0.0435473227040602,0.489211881744387
CASQ2,Calsequestrin-2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,30643,0.00942879301235891,0.02255892414964,-0.0347866983209355,0.0536442843456533,0.675988749496036
CASQ2,Calsequestrin-2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,30643,0.00700477261690151,0.0284248908653489,-0.0487080134791823,0.0627175587129853,0.805356826794082
CASQ2,Calsequestrin-2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,30643,0.00804667332689533,0.0255004973185576,-0.0419343014174776,0.0580276480712683,0.752354986171643
CASQ2,Calsequestrin-2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,47745,0.00268634601350676,0.0253277190053135,-0.0469559832369077,0.0523286752639212,0.915532899885512
CASQ2,Calsequestrin-2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,47745,0.093074656822974,0.0453302007976521,0.00422746325957593,0.181921850386372,0.040058577133276
CASQ2,Calsequestrin-2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,47745,-0.121834452806206,0.074082586683672,-0.267036322706203,0.0233674170937915,0.100070749478376
CASQ2,Calsequestrin-2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,47745,-0.0737964904702563,0.0672584777551361,-0.205623106870323,0.0580301259298104,0.272562140218623
CASQ2,Calsequestrin-2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,47745,0.031287246366109,0.0214235803384026,-0.0107029710971601,0.0732774638293781,0.144190459534444
CASQ2,Calsequestrin-2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,47745,-0.0283104063205617,0.0309006622988475,-0.0888757044263027,0.0322548917851793,0.359584735601166
CASQ2,Calsequestrin-2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,47745,-0.0102856025727742,0.0151198547893173,-0.0399205179598361,0.0193493128142877,0.496339483916596
CASQ2,Calsequestrin-2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32456,-0.0126006750794615,0.0226826436449099,-0.057058656623485,0.0318573064645619,0.578554171761014
CASQ2,Calsequestrin-2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32456,0.0469690139841928,0.0260924693047042,-0.00417222585302747,0.098110253821413,0.0718827310745161
CASQ2,Calsequestrin-2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32456,-0.0428656096128146,0.0337744814185337,-0.109063593193141,0.0233323739675114,0.204416803462397
CASQ2,Calsequestrin-2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32456,-0.00602029300165863,0.0117736811300672,-0.0290967080165903,0.017056122013273,0.609130739064647
CASQ2,Calsequestrin-2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35427,-0.00513584008578939,0.0115613286990129,-0.0277960443358548,0.017524364164276,0.656888124844434
CASQ2,Calsequestrin-2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35427,0.00240435573611848,0.0100912912199401,-0.017374575054964,0.022183286527201,0.811683531090371
CASQ2,Calsequestrin-2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35427,-0.00561431746892227,0.00947075022717872,-0.0241769879141926,0.012948352976348,0.553323212339239
CASQ2,Calsequestrin-2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35427,0.0507686966347751,0.0226342454754025,0.00640557550298615,0.0951318177665641,0.0249164482030895
CASQ2,Calsequestrin-2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35427,-0.0126547739194103,0.0135298250493284,-0.0391732310160939,0.0138636831772732,0.349641783384
CASQ2,Calsequestrin-2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35427,-0.000495661947717335,0.0158102631905653,-0.0314837778012252,0.0304924539057906,0.974990471486401
CASQ2,Calsequestrin-2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,47759,-0.0181332362536242,0.0229798129407072,-0.0631736696174103,0.026907197110162,0.430065000073626
CASQ2,Calsequestrin-2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,47759,0.0166640867962804,0.0145859546795356,-0.0119243843756093,0.0452525579681701,0.253268418547927
CASQ2,Calsequestrin-2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,47759,0.00757864865448093,0.0583556179441584,-0.10679836251607,0.121955659825031,0.8966703387843
CASQ2,Calsequestrin-2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,47759,0.0160326983683329,0.0144621444474403,-0.0123131047486501,0.044378501485316,0.267615260900531
CASQ2,Calsequestrin-2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,47759,0.00330396010459068,0.0171929596465966,-0.0303942408027386,0.03700216101192,0.847611217537791
CASQ2,Calsequestrin-2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),47759,-0.0158106583008305,0.0194229834696334,-0.0538797059013121,0.022258389299651,0.415642951407527
CASQ2,Calsequestrin-2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,47759,-0.00571608143160776,0.00692312833389492,-0.0192854129660418,0.00785325010282628,0.409011071222085
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28141,-0.0392453049438415,0.0220975415594733,-0.0825564864004091,0.00406587651272618,0.0758147751743092
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28141,-0.0212929462093999,0.0296941081792815,-0.0794933982407917,0.0369075058219919,0.473372300967297
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28141,0.0377996228569101,0.0195421031490115,-0.000502899315152461,0.0761021450289727,0.0531568120031943
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28141,0.0152861848620082,0.0175823857127804,-0.0191752911350414,0.0497476608590578,0.384683103412156
CASQ2,Calsequestrin-2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,47860,-0.00472205387288935,0.00790846805391724,-0.0202226512585671,0.0107785435127885,0.550454193321873
CASQ2,Calsequestrin-2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,47860,-0.027957717152127,0.0212287753648754,-0.0695661168672828,0.0136506825630287,0.187860675090121
CASQ2,Calsequestrin-2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,47860,-0.00459589909134513,0.00771737885010636,-0.0197219616375536,0.0105301634548633,0.551497739975199
CASQ2,Calsequestrin-2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,47860,-0.000417075883680674,0.00768447188110927,-0.0154786407706548,0.0146444890032935,0.956716408934798
CASQ2,Calsequestrin-2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,47860,0.000863918587597084,0.0110734687808475,-0.0208400802228641,0.0225679173980583,0.937815213250861
CASQ2,Calsequestrin-2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,47860,-0.000926566699055008,0.00979988293449981,-0.0201343372506746,0.0182812038525646,0.924674066810535
CASQ2,Calsequestrin-2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,47860,-0.00406205313273795,0.00823378578950036,-0.0202002732801587,0.0120761670146828,0.62177723361571
CASQ2,Calsequestrin-2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,47860,0.00257883015236786,0.0223191770841466,-0.0411667569325594,0.0463244172372951,0.908015536306296
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,40611,0.00896459471674211,0.0079891748495112,-0.00669418798829984,0.0246233774217841,0.26183970360269
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,40611,-0.00487030376140501,0.00883270031792013,-0.0221823963845285,0.0124417888617184,0.581370786808043
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,40611,0.000941763106707142,0.00889006195485058,-0.0164827583248,0.0183662845382143,0.915635739630358
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,40611,-0.00993602938847143,0.0113077117809419,-0.0320991444791175,0.0122270857021746,0.37957975582403
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,40611,0.00176859313700508,0.0080429779988148,-0.0139956437406719,0.0175328300146821,0.825957403659377
CASQ2,Calsequestrin-2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,47659,-0.00102019444987431,0.00829617483370878,-0.0172806971239435,0.0152403082241949,0.90213059890116
CASQ2,Calsequestrin-2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,47659,0.00273159056596015,0.00670210690241009,-0.0104045389627636,0.0158677200946839,0.683591743973626
CASQ2,Calsequestrin-2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,47659,0.00588609279403925,0.00731077825073249,-0.00844303257739643,0.0202152181654749,0.420755605324573
CASQ2,Calsequestrin-2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,47659,0.0209506425289115,0.0161581400834427,-0.0107193120346363,0.0526205970924593,0.19478178515903
CASQ2,Calsequestrin-2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),47670,0.00508692075862174,0.00758302947219528,-0.009775817006881,0.0199496585241245,0.502335750466624
CASQ2,Calsequestrin-2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,47670,0.0258756733438571,0.0137858609680158,-0.00114461415345386,0.052895960841168,0.0605344777868697
CASQ2,Calsequestrin-2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),47759,0.00103713045431463,0.00723222667325635,-0.0131380338252678,0.0152122947338971,0.885972339742051
CASQ2,Calsequestrin-2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,47759,0.0162584811997798,0.00821542049471004,0.00015625703014811,0.0323607053694115,0.0478255084749973
CASQ2,Calsequestrin-2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,47759,0.00876879359549597,0.0107226869328483,-0.0122476727928866,0.0297852599838786,0.413491463655603
CASQ2,Calsequestrin-2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,47759,-0.0101794123805051,0.0156525522640641,-0.0408584148180706,0.0204995900570605,0.515481859432806
CASQ2,Calsequestrin-2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,47759,0.0248915186027495,0.0159754575430562,-0.00642037818164055,0.0562034153871396,0.119220775152441
CASQ2,Calsequestrin-2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,47759,-0.00723614543641595,0.0207521322751193,-0.0479103246956499,0.033438033822818,0.727322147326034
CASQ2,Calsequestrin-2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",37667,0.000563234277106545,0.00471345107199957,-0.00867512982401262,0.00980159837822571,0.904884943330573
CASQ2,Calsequestrin-2,Physical activities,X864.Number of days or week walked 10+ minutes,47325,0.0156861057445116,0.0241299929085345,-0.0316086803562159,0.0629808918452392,0.515655644797514
CASQ2,Calsequestrin-2,Physical activities,X874.Duration of walks,43888,0.000949926456649826,0.00370020599777883,-0.00630247729899669,0.00820233021229634,0.797395651106369
CASQ2,Calsequestrin-2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,46409,-0.00305496955699019,0.023480284883572,-0.0490763279287913,0.042966388814811,0.896482285849323
CASQ2,Calsequestrin-2,Physical activities,X894.Duration of moderate activity,41249,-0.00209975853893026,0.0287348276304951,-0.0584200206947007,0.0542205036168402,0.941748385459935
CASQ2,Calsequestrin-2,Physical activities,X90087.No-wear time bias adjusted average acceleration,29411,-0.00511827877694157,0.00774714017230235,-0.0203026735146542,0.010066115960771,0.508856668847516
CASQ2,Calsequestrin-2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,46419,0.0569745913918203,0.0241574280362963,0.00962603244067965,0.104323150342961,0.0183591093332518
CASQ2,Calsequestrin-2,Physical activities,X914.Duration of vigorous activity,35996,-0.00150233333095389,0.00502472884818879,-0.0113508018734039,0.00834613521149613,0.764954628881412
